# Surgical robotics — semi-autonomous procedures

**Domain:** [Physical AI & Robotics](https://www.thestateofplay.ai/domain/physical-ai-robotics) · **Tier:** Bleeding Edge · **Trend:** Steady

Surgical robots that perform portions of procedures autonomously under surgeon supervision. Includes autonomous suturing and tissue manipulation; distinct from surgeon-assisted systems which augment rather than autonomously perform. Scope covers ML/AI-driven approaches; prior deterministic or rules-based automation is out of scope.

## Overview

Semi-autonomous surgical robotics hands discrete parts of an operation, such as suturing, retraction, resection and debridement, to a learned controller while the surgeon supervises rather than steers. It matters because it would turn robots from precision instruments into collaborators, but today it is a bleeding-edge practice, steady: laboratory, phantom and cadaver results keep improving, yet independent reviews agree that autonomous tissue work has not reached patients. The systems that do ship commercially automate adjacent functions like camera positioning or energy dosing, and are easily mistaken for the real thing. The deciding tension is in-human evidence, not engineering. Until several organisations show supervised autonomy succeeding in live surgery, while earning public and regulatory trust, it cannot move up.

## Current Landscape

Moon Surgical's Maestro remains the most visible commercial system in this practice, and even it is positioned cautiously. An equity review in OAE Publishing describes Maestro as a laparoscopic assistant model that is not fully autonomous. KARL STORZ has expanded its surgical robotics ecosystem through a partnership with Moon Surgical. NextInSurgery counts two of the five layers in Intuitive's AI roadmap as actually live.

Other vendors are moving towards autonomy-capable platforms. Andromeda Surgical raised a $15 million Series A for semi-autonomous HoLEP. LEM Surgical announced a second FDA 510(k) clearance for its Dynamis humanoid robotic surgical system. MedBot's Toumai gained an EU CE mark after a remote prostate surgery. An incisionless Korean surgical robot cleared the FDA and signed an exclusive Olympus deal. Commercial risk is real: J&J OTTAVA FDA approval was reported alongside Vicarious Surgical's liquidation.

The strongest new autonomy result is in soft-tissue oncology, though only in phantoms. Researchers working on occupancy network-guided partial nephrectomy describe the first vision-guided autonomous system to perform complete tumour resections. In patient-derived hydrogel phantoms, their robot performed eight consecutive autonomous resections comprising 77 electrosurgical cuts. All cuts achieved negative surgical margins, with a mean absolute margin error of 1.61 ± 0.48 mm. The authors frame this as a foundation for supervised autonomous tumour removal and claim no in-human validation.

Subtask autonomy on research platforms keeps outperforming learned baselines. The MACAW system autonomously removes tissue fragments for debridement on the da Vinci Research Kit, using a single monocular camera. Its authors report a 93% success rate at 304 fragments per hour across 100 physical trials, ahead of the ACT, Diffusion Policy, π0 and π0.5 baselines. A bimanual set-up held 92% success at 473 fragments per hour. Related work applies imitation learning to suture following in open surgery and trajectory divergence monitoring to dual-arm subtasks.

General-purpose humanoid hardware has entered surgical experiments. Researchers teleoperated humanoid robots in a first-of-its-kind surgery. Humanoid robots have also completed the first gallbladder removals in pigs. The hardware carries its own barrier: the Pentagon has flagged it as Chinese military technology. A separate framework proposes staged integration of embodied AI in the operating room rather than early autonomy.

No autonomous procedure has yet been performed in a human, according to a Journal of Robotic Surgery review of autonomous surgery and world models. The review credits supervised task automation in bowel anastomosis and self-correcting ex vivo cholecystectomy clipping and cutting. It finds that state-of-the-art generative models produce photorealistic but causally and strategically implausible surgical futures. Its authors argue that translation depends on prospective evaluation, defined stopping rules and clear accountability. More broadly, only 3 of 1,357 cleared AI medical devices were tested on patient outcomes.

Reviews of image-guided specialties also place autonomy at the research stage. A Frontiers in Robotics and AI review of 48 publications and five FDA records on spinal robots finds only a small group of research systems performing constrained tasks such as K-wire insertion under supervision. It concludes that these robots should currently be understood as surgeon-controlled enabling technologies. A Journal of Robotic Surgery review of robot-assisted seed brachytherapy finds that each control layer has advanced, but none has reached the threshold for clinical deployment.

Learned control remains fragile. Studies of adversarial attacks on learned surgical policies, and of overcoming imperfect kinematics through sim-to-real visuomotor learning, show that reliability is still a research problem. Recalls by Intuitive Surgical have put da Vinci reliability in focus. Outcome data for robotic surgery offer no cover either: robotic-assisted bariatric surgery is not associated with improved patient safety.

Regulators, payers and professional bodies are starting to address autonomy explicitly. South Korea has released regulatory guidelines for automated surgical robot systems. The FDA has outlined considerations for generative-AI-enabled medical devices. HHS says trust, not technology, is the barrier to AI in clinical care. A SAGES white paper addresses risk and liability in deploying AI systems for surgery. CMS's 2026 final rule proposal gives clinical AI a payment lane.

Public trust and access further limit adoption. A UAE survey of 508 adults found that 85% had heard of robotic-assisted surgery. Their acceptance turned on trust, perceived safety and concerns about machine autonomy and loss of human control. The OAE Publishing equity review estimates that 5 billion people lack access to safe and affordable surgical care. Broader adoption is held back by the absence of any in-human autonomous procedure, missing outcome trials, undefined liability and fragile learned policies.

## Tier History

- Research: 2020-01-01 – 2024-01-01
- Bleeding Edge: 2024-01-01 – present

## Evidence (176)

- **2026-09-27** — [Review: autonomous robotic surgery, surgical video and world models (Journal of Robotic Surgery)](https://link.springer.com/article/10.1007/s11701-026-04000-5?) (research-paper)
  Negative: an independent review states no autonomous procedure has yet been performed in a human, and finds that surgical world models produce causally implausible futures.
- **2026-09-14** — [Occupancy network-guided autonomous robotic partial nephrectomy in patient-derived phantoms](https://arxiv.org/abs/2609.16186v1) (research-paper)
  In phantoms, a vision-guided autonomous system completed 8 consecutive tumour resections (77 cuts), all margin-negative. It moves supervised soft-tissue autonomy beyond organ surfaces, but not yet into humans.
- **2026-09-11** — [UAE public perceptions of robotic-assisted surgery (n=508)](https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13566074/fullTextXML) (adoption-metric)
  Negative: in a UAE survey, 85% of respondents were aware of robotic surgery. Acceptance turned on trust, perceived safety and fears about machine autonomy, which points to a public-trust barrier.
- **2026-09-10** — [Robot-assisted spinal surgery: technological maturity and clinical evidence review](https://www.frontiersin.org/journals/robotics-and-ai/articles/10.3389/frobt.2026.1883508/full) (research-paper)
  Negative: a review of 48 papers and 5 FDA records finds spinal task autonomy confined to a few research systems. Its authors class current robots as surgeon-controlled enabling technologies.
- **2026-09-02** — [MACAW: semi-autonomous surgical debridement on the dVRK with a monocular camera](https://arxiv.org/html/2609.01961) (research-paper)
  Supervised autonomous debridement on the dVRK reached 93% success at 304 fragments/hour across 100 physical trials, beating the VLA baselines. The evidence is lab-only and self-reported.
- **2026-08-31** — [Dose control in robot-assisted seed brachytherapy: five-layer autonomy review](https://link.springer.com/article/10.1007/s11701-026-03868-7?) (research-paper)
  Negative: this review finds that every control layer for autonomous image-guided seed placement has advanced, but none has reached the threshold for clinical deployment.
- **2026-08-28** — [Intuitive's AI Roadmap Has Five Layers. Two Are Actually Live](https://www.nextinsurgery.com/article/intuitive-s-ai-roadmap-has-five-layers-two-are-actually-live) (industry-report)
  Audits Intuitive's five-layer AI roadmap against shipping reality: intraoperative guidance unfiled, augmented dexterity undeployed, supervised autonomy unannounced. Distinguishes roadmap vision from shipped production capability.
- **2026-08-21** — [The Robotic Surgery Monopoly Meets Its First Real Competition](https://www.triportfolio.no/company-analyses/intuitive-surgical-isrg-robotic-surgery-monopoly-thesis) (industry-report)
  Competitive landscape analysis: Intuitive maintains 11,710 installed systems; J&J OTTAVA FDA De Novo (July 22); Medtronic Hugo commercial launch; MicroPort Toumai overtook da Vinci in China unit share—'2026 is first year monopoly contested by opponents with real capability.'
- **2026-08-21** — [China's First Force-Feedback Laparoscopic Surgical Robot Achieves Clinical Breakthrough](https://www.vcbeathealth.com/article/61573) (case-study)
  Tuodao Medical's Tuoling system completed 3 human surgical cases remotely with force-feedback over 2,400 km. Demonstrates haptic feedback transition from lab to human surgery, establishing force sensing as data source for AI training.
- **2026-08-21** — [FDA Outlines Considerations for Gen-AI-Enabled Medical Devices](https://natlawreview.com/article/fda-seeks-public-feedback-regulatory-approach-generative-ai-enabled-medical-devices) (industry-report)
  FDA Digital Health Center proposed two-axis risk framework (clinical significance × autonomy level) for GenAI surgical systems with competency-based premarket evaluation, addressing semi-autonomous surgical autonomy regulation.
- **2026-08-21** — [Robotic Surgery Soars in Catalonia](https://barna.news/robotic-surgery-soars-in-catalonia/) (adoption-metric)
  Catalonia regional adoption surge: 9,402 robotic surgeries in 2025 (sevenfold increase from 1,288 in 2018), 24 hospitals participating, joint procurement achieving 21% cost reduction ($3.5M savings on €12.4M investment).
- **2026-08-21** — [Autonomy in Surgical Robotics | STORM Lab UK](https://stormlabuk.com/research/autonomy-in-surgical-robotics/) (industry-report)
  University of Leeds research lab developing shared autonomy in surgical robots using computer vision and machine learning. Peer-reviewed publications through 2026 on autonomous tissue manipulation and retraction with cadaver validation.
- **2026-08-19** — [1,357 AI medical devices cleared, 3 actually tested on patient outcomes](https://journals.plos.org/digitalhealth/article?id=10.1371/journal.pdig.0001597) (research-paper)
  Systematic review of all FDA-cleared AI/ML devices: only 0.2% (3 of 1,357) evaluated patient-centered outcomes like mortality or readmissions. Reveals validation gap and maturity barriers for surgical AI systems despite regulatory approval.
- **2026-08-18** — [Autonomous Surgery: The 2026 Landscape - NextInSurgery](https://www.nextinsurgery.com/article/autonomous-surgery-the-2026-landscape) (industry-report)
  Analyzes 2026 market landscape covering cleared systems (OTTAVA De Novo, Hugo commercial launch) and research autonomy (Johns Hopkins SRT-H). Includes negative signal of Vicarious Surgical liquidation, revealing capital runway constraints on autonomy development.
- **2026-08-17** — [Profound Medical (NASDAQ: PROF) targets higher TULSA throughput via real-time MRI software](https://www.stocktitan.net/sec-filings/PROF/8-k-profound-medical-corp-reports-material-event-8d578715c470.html) (product-ga)
  Profound Medical deploys real-time iMRI software upgrade to TULSA-PRO prostate ablation platform with 'supervised robotic autonomy.' Active deployment: 4 procedures/day (current), roadmap to 6/day. FDA-cleared US + 6 international markets.
- **2026-08-17** — [MHRA AI Airlock & AI Regulation in UK Trials](https://casrai.org/guides/mhra-ai-uk-clinical-research) (industry-report)
  UK regulatory sandbox program with £3.6M funding and active multi-phase structure (Phases 1-2 completed, Phase 3 in design). Demonstrates regulatory preparation for AI-enabled surgical devices including autonomy management and adaptive systems.
- **2026-08-17** — [Minimally Invasive Surgery Market: Trends & Forecasts for 2026](https://www.nextmsc.com/blogs/minimally-invasive-surgery-market-trends-forecasts-for-2026) (adoption-metric)
  Intuitive revised 2026 guidance to 13.5-15.5% procedure growth; OTTAVA FDA De Novo July 22. Safety signal: 43% of FDA-authorized AI-enabled medical devices recalled <1 year (vs ~20% non-AI), reflecting validation and reliability barriers.
- **2026-08-17** — [Medical Robots in China: Surgical, Rehabilitation, and Hospital Automation Strategy](https://chozan.co/medical-robots/) (adoption-metric)
  China's regulatory shift from approval-focused to clinical-value assessment. MicroPort Toumai SP deployment at Peking University Shougang Hospital with structured training programs. Signals commercialization maturity and mainstream adoption pathway.
- **2026-08-13** — [Surgical Disparities and the Robot: An Innovators' Perspective](https://www.oaepublish.com/articles/ais.2026.39) (opinion)
  Peer-reviewed perspective from Johns Hopkins: documents capital cost barriers ($2M system, $3-5K per case consumables) restricting adoption to high-income settings; global installed base shows 6,087 US vs 541 rest-of-world, revealing equity constraints on semi-autonomous deployment.
- **2026-08-11** — [Update in Robotic Microsurgery](https://headneckroboticsurgery.com/2026/08/11/update-in-robotic-microsurgery/) (opinion)
  Clinician critical assessment: robotic and manual microsurgery procedures achieve comparable clinical outcomes; identifies current maturity limitation—outcome parity despite technical sophistication—constraining clinical utility argument for autonomous microsurgery.
- **2026-08-10** — [Trajectory Divergence Horizon Decision for Reliable Dual-Arm Surgical Subtask Manipulation](https://arxiv.org/abs/2608.09125) (research-paper)
  Demonstrates dual-arm VLA model adaptive execution control on da Vinci-like hardware with measured success-rate improvements: 55%→60% needle manipulation, 55%→80% tissue manipulation, establishing necessity of adaptive execution for reliable surgical robotics deployment.
- **2026-08-10** — [Surgical Robots Aren't All the Same: A Field Guide to Autonomy Levels](https://www.linkedin.com/pulse/surgical-robots-arent-all-same-field-guide-autonomy-levels-dixit-qe1ec) (opinion)
  Cites 2024 FDA systematic review: 86% of cleared surgical robots remain at Level 1 (continuous surgeon control), only 6% at Level 3 (conditional autonomy), documenting critical gap between marketing claims and regulatory-cleared autonomous capabilities.
- **2026-08-06** — [Humanoid Robots in the Operating Room: A Framework for Staged Integration of Embodied AI](https://www.linkedin.com/posts/pranavrajpurkar_humanoid-robots-in-the-operating-room-a-activity-7491170596819529729-j5qx) (opinion)
  npj Digital Medicine perspective by leading AI researchers proposing staged embodied AI deployment: perioperative tasks first, high-risk surgical maneuvers last—providing critical governance framework cautioning against premature autonomy despite technical capability.
- **2026-08-05** — [AI-Based Single-Shot Structured-Light Depth Reconstruction for Real-Time Laparoscopic Surgical Guidance](https://arxiv.org/abs/2608.05109v1) (research-paper)
  Demonstrates real-time AI-enabled laparoscopic depth perception at 26 Hz with 3.7mm MAE accuracy, enabling enabling technology for autonomous scene understanding and manipulation critical to semi-autonomous laparoscopic procedures.
- **2026-08-05** — [Fatal Adverse Event in Robotic-Assisted Laparoscopic Prostatectomy](https://s-bi.com/wp_diary/kou/2026/08/05/post-90143.html) (news-coverage)
  Documented fatal medical accident: patient died from robotic-assisted prostatectomy vascular perforation (2022), highlighting concrete safety risks in surgeon-operated systems and postoperative decision-making failures informing autonomous system liability frameworks.
- **2026-08-04** — [Andromeda Surgical Raises $15 Million Series A for Semi-Autonomous HoLEP](https://runtimewire.com/article/andromeda-surgical-raises-15-million-autonomous-surgery) (adoption-metric)
  Series A funding ($15M, $30M total) for Beacon semi-autonomous HoLEP platform with active ASTRA clinical trial recruiting 54 patients across 3 sites (Chile/NZ), demonstrating venture capital commitment to autonomous prostate surgery with defined pathway.
- **2026-08-04** — [Researchers Teleoperate Humanoid Robots in First-of-Its-Kind Surgery](https://www.medicaldesignandoutsourcing.com/university-california-san-diego-humanoid-robot-surgery/) (news-coverage)
  UC San Diego preclinical feasibility study with teleoperated humanoid robots performing laparoscopic gallbladder removal; independent trade-press explicitly notes latency issues, multiple recalibrations, and longer procedure times constraining practical surgical application.
- **2026-08-04** — [Fully Autonomous Surgical Robotics Market Research Report 2034](https://marketintelo.com/report/fully-autonomous-surgical-robotics-market) (industry-report)
  Market research valuating fully autonomous surgical robotics at $5.2B (2025) projected to $47.8B (2034) at 28.5% CAGR, identifying FDA/EMA regulatory pathway acceleration as maturity signal supporting ecosystem expansion.
- **2026-07-30** — [This mind-blowing robot performs surgery on its own—experts are stunned by the results](https://www.futura-sciences.com/en/this-mind-blowing-robot-performs-surgery-on-its-own-experts-are-stunned-by-the-results_36497/) (news-coverage)
  Johns Hopkins SRT-H system performs independent autonomous surgical task execution (gallbladder removal phase) using transformer-based ML; research demonstrates progress in procedural autonomy scalability beyond isolated task demonstrations.
- **2026-07-27** — [Surgical robots](https://registry.deploy.report/surgical) (industry-report)
  DEPLOY Registry: verified database tracking 47 companies, 55 surgical robot models, and 52 commercial deployments with 24 documented safety incidents, providing verified ecosystem breadth and critical safety signal balance.
- **2026-07-26** — [Incisionless Korean Surgical Robot Clears FDA, Signs Exclusive Olympus Deal](https://en.sedaily.com/technology/2026/07/26/incisionless-korean-surgical-robot-clears-fda-signs) (product-ga)
  Endorobotics' ROBOPERA obtains FDA 510(k) approval for endoscopic surgical automation, demonstrating ecosystem expansion beyond da Vinci into endoscopic semi-autonomous suturing with major vendor partnership (Olympus global exclusivity).
- **2026-07-24** — [Anne Osdoit - srs2026](https://www.linkedin.com/posts/anne-osdoit-5812807_srs2026-activity-7486416807701073921-ZIF1) (conference-talk)
  Moon Surgical CEO reports SRS 2026 peer-reviewed data on Maestro: laparoscopic sleeve gastrectomy achieving significant reduction in procedural time variability and duration, advancing clinical evidence base for semi-autonomous surgical assistance.
- **2026-07-23** — [Vicarious Surgical Liquidation, J&J OTTAVA FDA Approval](https://www.linkedin.com/posts/activity-7485970022230753282-Y6Pe) (opinion)
  Critical analysis of Vicarious Surgical's $300M pre-clinical failure (zero patients) contrasts with OTTAVA's market-validated approach; documents innovation portfolio risk and commercialization barriers constraining autonomous surgical robotics scaling despite technical feasibility.
- **2026-07-22** — [KARL STORZ Expands Surgical Robotics Ecosystem with Moon Surgical and SOVATO](https://www.linkedin.com/posts/jack-shuang-hou-75314a2b3_expands-partnerships-maestro-activity-7485822605078441984-NI1K) (adoption-metric)
  KARL STORZ partnership signals ecosystem shift toward open surgical robotics platforms with AI-native workflow automation; market projection $9.1B (2026) → $20.8B (2034) at 10.9% CAGR reflects semi-autonomous systems as fastest-growing segment.
- **2026-07-22** — [Surgery and the Appropriate Technology Is Sorting Itself Into Lanes](https://www.linkedin.com/pulse/surgery-appropriate-technology-sorting-itself-lanes-joe-mullings-t1wne) (opinion)
  Independent analyst quantifies Maestro semi-autonomous deployment: 4 procedures/week in French ambulatory settings, demonstrating market niche convergence toward high-volume predictable procedures as primary semi-autonomous use case.
- **2026-07-21** — [A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide](https://news.medtronic.com/2026-07-21-A-new-era-for-surgery-with-real-time-ai-Medtronic-to-unveil-Touch-Surgery-TM-Aide,-the-next-generation-compute-platform-for-the-operating-room-at-Society-of-Robotic-Surgery-2026) (product-ga)
  Medtronic's real-time AI compute platform (NVIDIA Holoscan infrastructure) establishes vendor infrastructure for autonomous surgical functions; first FDA-cleared application is decision-support, positioning foundation for autonomous capability evolution.
- **2026-07-21** — [ISRG Emerging Market Adoption Draws Investor Scrutiny in 2026](https://pomegra.io/news/isrg-emerging-market-adoption-draws-investor-scrutiny-in-2026) (adoption-metric)
  Market penetration barrier documented: fewer than 10% of emerging-market hospitals can afford advanced robotic platforms at current price; capital constraints constraining adoption trajectory despite ecosystem maturation in developed markets.
- **2026-07-21** — [MedTech Monitor (July 21): GLP-1s, Catheter Recall, FTC Antitrust Charges, and More](https://www.linkedin.com/pulse/medtech-monitor-july-21-glp-1s-catheter-recall-ftc-antitrust-charges-rkn8e) (news-coverage)
  Critical negative signal: GLP-1 medications driving high single-digit decline in da Vinci bariatric procedures (Q2 2026); structural market headwind from pharmaceutical alternatives reducing procedure demand despite new vendor ecosystem entry.
- **2026-07-20** — [The Robotics Race Is the Hiring Race: Why Surgical Robotics' Competitive Shift Is Creating MedTech's Most Urgent Talent Battle](https://www.44international.com/the-robotics-race-is-the-hiring-race-why-surgical-robotics-competitive-shift-is-creating-medtechs-most-urgent-talent-battle/) (industry-report)
  Market analysis documents competitive tier entry (Medtronic Hugo, CMR Versius Plus, J&J Ottava, Moon Surgical); projections $13.69B (2025) → $27.14B (2030); AI segment growing 17.8% annually signaling ecosystem maturation beyond Intuitive monopoly.
- **2026-07-15** — [HHS says trust, not technology, is the barrier to AI in clinical care](https://www.paubox.com/blog/hhs-says-trust-not-technology-is-the-barrier-to-ai-in-clinical-care) (industry-report)
  Official HHS position from 7,000+ public comments: governance and trust infrastructure, not regulatory speed or technology maturity, are primary adoption barriers for AI-enabled surgical systems including semi-autonomous robotics.
- **2026-07-13** — [Stable Tracking-in-the-Loop Control of Cable-Driven RCM Surgical Manipulators under Erroneous Kinematic Chains](https://pubmed.ncbi.nlm.nih.gov/42396094/) (research-paper)
  Peer-reviewed IEEE Robotics and Automation Letters: solves critical kinematic uncertainty for RCM surgical manipulators enabling autonomous subtasks (suturing, blood suction, tumor resection), directly enabling reliable autonomous surgical task execution.
- **2026-07-12** — [Humanoid Robots Complete First Gallbladder Removals in Pigs](https://www.roboticsintl.com/article/humanoid-robots-complete-first-gallbladder-removals-in-pigs) (news-coverage)
  Johns Hopkins autonomous surgical robotics milestone: humanoid robots made 180 micro-decisions per minute, autonomously applied cautery to control arterial bleeding, demonstrating genuine adaptive autonomous capability and regulatory pathway (IDE application Q4 2026).
- **2026-07-11** — [Humanoid Robots Perform First Live Surgery: Pentagon Flags the Hardware as Chinese Military Tech](https://www.techtimes.com/articles/320157/20260711/humanoid-robots-perform-first-live-surgery-pentagon-flags-hardware-chinese-military-tech.htm) (news-coverage)
  Critical negative signal: UC San Diego humanoid platform (Unitree G1) flagged as Chinese military company (June 2026), carries wormable security exploit, transmits sensor data to China—concrete geopolitical adoption barriers extending regulatory/clinical pathway.
- **2026-07-08** — [In vivo feasibility study of humanoid robots in surgery](https://humanoid-surgeon.github.io/) (research-paper)
  Nature publication documenting teleoperated humanoid robots (Unitree G1) performing live laparoscopic cholecystectomy on porcine models with feasibility comparison to da Vinci standards, advancing general-purpose platform viability for surgical deployment.
- **2026-07-08** — [AI Copilots for Robotic Surgery Reach a Clinical Milestone](https://nexi.fund/ai-surgical-copilot-2026/) (industry-report)
  Ecosystem maturity assessment: 4 independent research groups and 3 medical vendors fielding working AI copilot prototypes; 35% of new surgical robot installations now AI-enabled; competitive fragmentation away from da Vinci monopoly signaling market transition.
- **2026-07-07** — [Robotic-Assisted Bariatric Surgery Is Not Associated with Improved Patient Safety](https://www.facs.org/for-medical-professionals/news-publications/news-and-articles/acs-brief/july-7-2026-issue/robotic-assisted-bariatric-surgery-is-not-associated-with-improved-patient-safety/) (research-paper)
  Large national cohort (N=949,507) showing robotic-assisted bariatric surgery associated with higher 30-day serious adverse event risk than conventional laparoscopy, critical negative signal for platform safety maturity constraining semi-autonomous feature integration.
- **2026-07-07** — [CMS 2026 Final Rule Proposal: Clinical AI get a Payment Lane and the Campus Premium Ends](https://techysurgeon.substack.com/p/cms-2026-final-rule-proposal-clinical?r=3adnor) (industry-report)
  CMS formally established reimbursement pathway for algorithm-driven clinical care, removing identified economic barrier to semi-autonomous surgical procedure adoption and payment infrastructure gap constraining market expansion.
- **2026-06-27** — [MedBot Toumai surgical robot gains EU CE mark for remote prostate surgery](https://meteoraweb.com/en/news/medbot-toumai-surgical-robot-gains-eu-approval-after-remote-prostate-surgery-success) (product-ga)
  CE marking regulatory approval for Shanghai MicroPort MedBot's Toumai system with named landmark clinical procedure: remote prostatectomy from London to Gibraltar (March 2026), demonstrating ecosystem diversification beyond incumbent vendors into semi-autonomous remote operation.
- **2026-06-26** — [What the Johns Hopkins autonomous surgery result proved and where it stops](https://webiano.digital/what-the-johns-hopkins-autonomous-surgery-result-proved-and-where-it-stops/) (research-paper)
  In-depth technical analysis of Johns Hopkins SRT-H system achieving 100% success on clipping-and-cutting phase of laparoscopic cholecystectomy across 8 ex vivo specimens with step-level autonomy, explicit about gaps (ex vivo tissue, single phase, unresolved liability/regulation).
- **2026-06-23** — [LEM Surgical Announces second FDA 510(k) Clearance for Dynamis Robotic Surgical System](https://www.biospace.com/press-releases/lem-surgical-announces-second-fda-510k-clearance-for-next-generation-humanoid-robotic-surgical-system) (product-ga)
  FDA 510(k) clearance for LEM Surgical Dynamis dual-arm humanoid architecture with continuous independent vertebra tracking and bilateral workflow, signaling second major vendor achieving approval for hard-tissue autonomous navigation and stabilization.
- **2026-06-19** — [Overcoming Imperfect Kinematics in Surgical Robotics Through Sim-to-Real Visuomotor Learning](https://arxiv.org/abs/2606.21396) (research-paper)
  Peer-reviewed ICRA 2026 paper addresses foundational technical barrier—kinematic inaccuracies in surgical robots—through learned visual feedback policy, demonstrating sim-to-real transfer on da Vinci Research Kit for robust autonomous control methodology.
- **2026-06-19** — [Navigating the Soft-Tissue Field: A Grounded Review of Surgical Robots](https://robotwale.com/article/surgical-robots-soft-tissue-field-india-context) (opinion)
  Critical review explicitly stating 'No system currently performs autonomous surgery without direct human oversight' and autonomy claims are 'limited to research environments,' providing essential negative signal about current state of semi-autonomous deployment readiness.
- **2026-06-10** — [Adversarial Attacks on Learned Policies for Surgical Robotic Tasks](https://arxiv.org/abs/2606.11535v1) (research-paper)
  Critical research documenting vulnerability of end-to-end learned surgical policies to adversarial attacks, with 61% success-rate reduction on debridement and suturing subtasks, revealing robustness limitations in safety-critical semi-autonomous execution.
- **2026-06-08** — [Risk and Liability in the Deployment of AI Systems for Surgery: a SAGES white paper](https://cris.maastrichtuniversity.nl/en/publications/risk-and-liability-in-the-deployment-of-ai-systems-for-surgery-a-/) (industry-report)
  SAGES professional-society white paper identifying inadequate regulatory and legal frameworks for AI-assisted surgery, proposing tripartite risk framework (AI system, clinician, institutional risks) and calling for robust governance—evidence of maturity barriers.
- **2026-06-02** — [Opportunities and obstacles in harnessing intraoperative data](https://www.frontierspartnerships.org/journals/journal-of-abdominal-wall-surgery/articles/10.3389/jaws.2026.16301/full) (opinion)
  Identifies critical infrastructure gap: only 3% of surgical platforms offer conditional decision-making despite high-fidelity intraoperative data availability; lacking standardized data ontology and interoperability standards constrains autonomous task execution scaling.
- **2026-06-01** — [South Korea Releases Regulatory Guidelines for Automated Surgical Robot Systems](https://v.daum.net/v/20260601091515535) (industry-report)
  South Korea's Ministry of Food and Drug Safety formalized regulatory approval framework for semi-autonomous surgical robots (autonomous bone cutting, screw insertion) effective December 2025, directly advancing regulatory infrastructure for autonomous surgical deployment.
- **2026-05-31** — [NVIDIA Isaac for Healthcare — Safe Testing of Autonomous Medical Robot Behavior](https://isaachealthcaredocs.com/task/faq/safe-testing-autonomous-medical-robots) (product-ga)
  NVIDIA Isaac platform enables software-in-the-loop and hardware-in-the-loop simulation of autonomous surgical robots with digital twins prior to clinical trials, demonstrating maturation of development and validation infrastructure for semi-autonomous surgery.
- **2026-05-30** — [Safety-Critical Cybersecurity Architecture for Robotic-Assisted Surgical Systems](https://computerfraudsecurity.com/index.php/journal/article/view/1085) (research-paper)
  Practitioner-grounded cybersecurity architecture framework for multi-vendor integrated surgical robots achieved 73% residual risk reduction; demonstrates engineering maturity and safety infrastructure required for autonomous surgical system deployment.
- **2026-05-27** — [Comparative safety of robotic-assisted vs laparoscopic cholecystectomy in contemporary practice](https://www.eurekalert.org/news-releases/1129454) (research-paper)
  JAMA Surgery analysis of Medicare beneficiaries 2020–2023 documents robotic-assisted adoption growth alongside higher bile duct injury risk vs laparoscopic approach—critical negative signal on outcomes despite platform expansion.
- **2026-05-27** — [Imitation Learning for Robot Assistance in Open Surgery: A Multi-Policy Evaluation on Suture Following](https://arxiv.org/abs/2605.28736) (research-paper)
  Peer-reviewed benchmark of imitation learning policies for autonomous robotic suturing achieved 92% stitch completion in real surgeon-robot trials, demonstrating feasibility of semi-autonomous procedure execution in open surgery.
- **2026-05-27** — [Time-series and thematic analyses of clinical utilities and operational issues in early clinical studies of the da Vinci surgical system](https://pubmed.ncbi.nlm.nih.gov/42201559/) (research-paper)
  Systematic review reveals utilities recognized in 13.2 months vs operational issues emerging after 26.0 months during device adoption, explaining why evidence sets appear skewed toward benefits early in semi-autonomous technology maturation cycles.
- **2026-05-27** — [Ground-Breaking Technology - Surgical Robotics Industry Awards](https://surgicalroboticsindustryawards.com/categories/groundbreaking-technology/) (industry-report)
  JASPER (ForSight Robotics) achieved world-first fully robot-assisted cataract surgery in human (2026), extending semi-autonomous surgical execution beyond traditional surgical domains into ophthalmology.
- **2026-05-27** — [Intuitive Surgical Recalls Put Da Vinci Reliability And Valuation In Focus](https://www.sahmcapital.com/news/content/intuitive-surgical-recalls-put-da-vinci-reliability-and-valuation-in-focus-2026-05-27) (news-coverage)
  Class I recalls of da Vinci systems (incomplete staple lines, arm screw breakage) documented May 2026 raise critical product reliability concerns, regulatory scrutiny, and adoption barriers during escalating autonomous feature integration.
- **2026-05-27** — [New RCSI report charts course for safe and effective use of AI in surgery](https://www.rcsi.com/surgery/news-and-events/news/news-article/2026/05/rcsi-report-charts-course-for-safe-use-of-ai-in-surgery) (industry-report)
  Royal College of Surgeons Ireland governance framework recommends AI deployment as support tool in human-in-the-loop model, establishing institutional consensus on supervised autonomy and embedding AI in surgical education as prerequisites for safe adoption.
- **2026-05-26** — [Surgical Robot Systems Market Growth Outlook to 2035: AI Integration and Ambulatory Surgery Expansion](https://www.indexbox.io/blog/surgical-robot-systems-market-forecast-points-higher-toward-2035-driven-by-ai-integration-and-ambulatory-surgery-expansion/) (industry-report)
  IndexBox market analysis explicitly identifies AI integration for procedural planning and intraoperative guidance as primary demand driver for surgical robotics market growth, showing analyst-level recognition of semi-autonomous surgery as market transformation.
- **2026-05-24** — [Shuairu single-port surgical robot first commercial installation in Germany](https://finance.sina.com.cn/wm/2026-05-24/doc-inhyzeae3195588.shtml) (case-study)
  Chinese Shuairu robot CE-marked and deployed at Munich Klinik Bogenhausen (May 2026), first DAcH region deployment; documented cases show single-port lung resection and adrenal resection with acceptable outcomes, breaking US monopoly in premium surgical robotics in Europe.
- **2026-05-23** — [Integration of a collaborative robotic platform in laparoscopic cholecystectomy: safety, feasibility, and operative time variability](https://pubmed.ncbi.nlm.nih.gov/42174318/) (case-study)
  Prospective study at Stanford and European centres: 79 Maestro-assisted vs 79 conventional laparoscopic cholecystectomies showed 35% reduction in operative time variability with no device-related complications, validating semi-autonomous surgical assistance in production clinical setting.
- **2026-05-23** — [Johnson & Johnson (JNJ) Announces Positive Clinical Study Results for OTTAVA Robotic Surgical System](https://www.insidermonkey.com/blog/johnson-johnson-jnj-announces-positive-clinical-study-results-for-ottava-robotic-surgical-system-1767931/) (product-ga)
  FORTE study: J&J OTTAVA completed 30-patient gastric-bypass trial with 100% procedures completed autonomously without conversion to manual surgery, met primary safety/performance endpoints, and filed FDA De Novo application for multi-procedure general surgery, signaling second major vendor entry into semi-autonomous surgical deployment.
- **2026-05-22** — [Beyond adoption: why surgical AI must meet Evidence, Ethics, and Equity standards before deployment](https://www.bjsacademy.com/bjs-academy/cutting-edge-blog/beyond-adoption-why-surgical-ai-must-meet-evidence-ethics-and-equity-standards-before-deployment) (opinion)
  Liverpool, Madrid, and Italian surgeons provide critical practitioner assessment: surgical AI deployment lacks evidence prospective validation, ethical safeguards against automation bias, and equity protection against dataset bias—identifying governance gaps limiting safe semi-autonomous surgical deployment.
- **2026-05-20** — [Medtronic and Asan Medical Center sign MOU to establish strategic partnership in robotic surgery](https://news.medtronic.com/2026-05-20-Medtronic-and-Asan-Medical-Center-sign-MOU-to-establish-strategic-partnership-in-robotic-surgery) (press-release)
  Hugo RAS platform deployed across 30+ countries with tens of thousands of procedures; Asan Medical Center (Seoul, major academic institution) partnership signals institutional recognition at leading-edge centres and geographic diversification beyond US market.
- **2026-05-18** — [Learning-Based Adaptive Control for Surgical Robotic Exposure Task on Deformable Tissues](https://arxiv.org/abs/2605.17927) (research-paper)
  Learning-based adaptive control for autonomous tissue retraction with zero-shot generalization across similar tasks; real-world experiments on deformable materials accepted to RSS 2026, demonstrating technical progress in autonomous surgical subtask execution.
- **2026-05-14** — [AI-powered surgical robots could transform surgery if regulatory gaps are closed – newly-released paper](https://www.kcl.ac.uk/news/ai-powered-surgical-robots-could-transform-surgery-if-regulatory-gaps-are-closed-newly-released-paper) (opinion)
  King's College London analysis identifies 'embodied AI' regulatory blind spot: how regulators manage systems that learn and evolve post-approval, prevent dataset bias reinforcing healthcare inequalities, and address global research/industry concentration imbalances remain unresolved governance challenges.
- **2026-05-13** — [Artificial Intelligence Across the Surgical Oncology Continuum: Decision Support, Operative Intelligence, and a Translation-First Roadmap](https://premierscience.com/pjs-26-1588/) (research-paper)
  Stanford, UCLA, Johns Hopkins framework for translating AI/ML into surgical robotics autonomy identifies critical evidentiary gaps—limited data on generalization across institutions and clinical utility under routine conditions—emphasizing need for safety assurance coupling algorithmic performance with human-system interaction.
- **2026-05-13** — [Autonomous Pedicle Screw Placement: Is Spine Robotics Ready for the Next Step?](https://thespinemarketgroup.com/autonomous-pedicle-screw-placement-is-spine-robotics-ready-for-the-next-step/) (opinion)
  Industry analyst assessment of autonomous surgical robotics barriers: surgeon acceptance of autonomous execution differs from guidance; regulatory caution around autonomy near neural structures; liability frameworks undefined—concluding that supervised autonomy (surgeon defines strategy, monitors execution, intervenes when needed) is most realistic near-term model.
- **2026-05-11** — [Surgeon Volume and Clinical Outcomes After Robotic Elective and Emergency General Surgery](https://pmc.ncbi.nlm.nih.gov/articles/PMC13162076/) (research-paper)
  National cohort study of 185,000+ robotic general surgery cases: surgeon's annual case volume is critical outcome determinant, informing credentialing standards and safe scaling pathways for semi-autonomous surgical capabilities across institutions.
- **2026-05-07** — [Evolving surgical teams in the age of artificial intelligence and robotics](https://www.frontiersin.org/journals/science/articles/10.3389/fsci.2026.1783803/full) (industry-report)
  King's College London experts forecast surgical robotics shift toward autonomous systems with human-in-the-loop control, embodied AI, and autonomous surgical assistance—establishing the technical trajectory for semi-autonomous procedure adoption.
- **2026-05-07** — [An emerging artificial intelligence-enabled partnership between surgical teams and robotics to enhance patient care](https://www.frontiersin.org/journals/science/articles/10.3389/fsci.2026.1838651/full) (opinion)
  Johns Hopkins expert H. Russell Taylor frames core challenges delimiting feasible semi-autonomous surgery scope: specifying clinical intent to autonomous systems and ensuring safe execution within defined constraints; proposes hybrid approaches combining AI with patient-specific digital twins.
- **2026-05-05** — [Summary of Field Safety Notices April 2026](https://www.hpra.ie/safety-information/safety-notices/article/summary-of-field-safety-notices-april-2026) (news-coverage)
  Irish HPRA (regulatory authority) issued device modification guidance for da Vinci X & Xi systems in April 2026, documenting ongoing operational/safety concerns affecting deployed installed base and constraining autonomous feature integration.
- **2026-05-04** — [Intuitive Surgical Raises 2026 Procedure Guidance After a 40% EBIT Jump](https://tikr.com/blog/intuitive-surgical-raises-2026-procedure-guidance-after-a-40-ebit-jump-analysts-price-isrg-above-700) (adoption-metric)
  Q1 2026: da Vinci procedures grew 16% to 847K cases, Ion surged 39% to 43K cases; management raised 2026 guidance to 14-16% da Vinci growth, though China policy uncertainty and GLP-1 drug competition signal market headwinds.
- **2026-05-04** — [ISRG: Policy Shifts And Platform Adoption Will Shape Balanced Risk Reward Profile](https://simplywall.st/community/narratives/us/healthcare/nasdaq-isrg/intuitive-surgical/vw20ztgf-global-healthcare-cost-pressures-and-tariffs-will-depress-margins/updates/7-analysts-have-trimmed-the-fair-value-estimate-for-intuitive) (opinion)
  Analyst intelligence documents multiple Class II FDA recalls of da Vinci reusable instruments (broken pitch cables across monopolar scissors, graspers, drivers, hooks, forceps) with worldwide distribution and ongoing status, signaling systemic quality concerns in deployed base.
- **2026-05-01** — [Ethical Challenges of Autonomous Surgical Robots and the Construction of A Systemic Ethical Governance Framework](https://bhxb.buaa.edu.cn/bhsk/en/article/doi/10.13766/j.bhsk.1008%E2%88%922204.2026.0299) (research-paper)
  Peer-reviewed analysis of autonomy classification systems and governance frameworks for autonomous surgical robots; proposes mechanisms for responsibility attribution, algorithm transparency, and safety monitoring as prerequisites for responsible innovation.
- **2026-04-24** — [Moon Surgical erhält FDA-Zulassung für ScoPilot unter Maestro](https://www.finanznachrichten.de/nachrichten-2025-03/64861396-moon-surgical-erhaelt-fda-zulassung-fuer-scopilot-unter-maestro-die-branchenweit-erste-ki-gestuetzte-intraoperative-funktion-die-auf-nvidia-holoscan-ba-006.htm) (product-ga)
  FDA clearance of Moon Surgical's ScoPilot—AI-driven autonomous camera positioning on Maestro platform. First FDA-cleared AI intraoperative function running natively on commercial surgical robotics, deployed across 1,100+ patients.
- **2026-04-24** — [Microsurgery Robot Market Size, Share & 2031 Growth Trends Report](https://www.mordorintelligence.com/industry-reports/microsurgery-robot-market) (industry-report)
  Market analysis projecting microsurgery robot market at 17.12% CAGR for semi-autonomous systems (fastest-growing segment) through 2031. Documents 900+ clinical cases in Europe; semi-autonomous systems reducing proficiency curve from 40 manual cases to 15 cases.
- **2026-04-21** — [AI-Powered Robot Autopilot Used in World-First Spine Surgery](https://briefglance.com/articles/ai-powered-robot-autopilot-used-in-world-first-spine-surgery) (case-study)
  World-first deployment of Medtronic Stealth AXiS with LiveAlign real-time autonomous vertebral tracking maintaining robotic alignment throughout spine procedures. Complex multi-level fusion with AI-integrated surgical planning and continuous segmental navigation.
- **2026-04-20** — [FDA Concerned About Adverse Events from Intuitive Surgical](https://intellectia.ai/news/stock/fda-concerned-about-adverse-events-from-intuitive-surgical) (news-coverage)
  FDA alert documenting da Vinci curved-tip stapler failures with incomplete staple line formation on blood vessels, causing 4 serious injuries and 1 death by February 2026. Critical safety barrier constraining surgical robotics platform deployment.
- **2026-04-19** — [A Surgeon's Deep Dive on Autonomous Robot Surgery](https://www.youtube.com/watch?v=U1fUrsQNSiM) (opinion)
  Practicing surgeon's critical technical analysis of Johns Hopkins SRT-H system, separating realistic capabilities from media hype about autonomous procedures and assessing near-term clinical implications of autonomous surgical robotics.
- **2026-04-18** — [First international consensus on how to design, test and evaluate robotic systems for stroke treatment](https://medicalxpress.com/news/2026-04-international-consensus-robotic-treatment.html) (industry-report)
  King's College London position statement establishing international consensus standards for semi-autonomous robotic mechanical thrombectomy navigation. Notes AI-assisted MT robotics 'not yet ready for routine clinical use' despite hardware-level autonomy demonstration.
- **2026-04-17** — [Cleared 510(K) - Maestro System (REF100) (K250984)](https://fda.innolitics.com/submissions/SU/subpart-b%E2%80%94diagnostic-devices/QZB/K250984) (product-ga)
  FDA 510(k) clearance for Moon Surgical's Maestro System with ML-based surgical instrument detection and tracking. Class II medical device for laparoscopic procedure support with motorized arms and autonomous position maintenance.
- **2026-04-15** — [Autonomous robotic surgery patent landscape 2026 - PatSnap](https://www.patsnap.com/resources/blog/articles/autonomous-robotic-surgery-patent-landscape-2026-2/) (industry-report)
  Patent landscape analysis of 70+ records (2011–2026) documenting ecosystem-wide R&D maturation: foundational (2011–2017), rapid scale-up (2018–2021), AI integration (2022–2024), and autonomous execution frontier (2025–2026) with consistent master-slave/cooperative-control architecture.
- **2026-04-13** — [A Study About Remote and Local Liver Surgery - Clinical Trials](https://clinicaltrials.gov/study/NCT07524699) (product-ga)
  Chinese clinical trial registry documenting MP1000/MP2000 systems approved by NMPA with 100% success rate across urology, gynecology, general, and thoracic surgeries. Edge Cloud remote surgery system NMPA-approved November 2025, signaling competing vendor ecosystem.
- **2026-04-10** — [Moon Surgical Company Timeline](https://moonsurgical.com/company) (adoption-metric)
  Maestro semi-autonomous system progression: 50 first-in-human procedures (2022), FDA clearance (Dec 2022), CE mark (Apr 2023), 200 EU commercial procedures (Apr 2024), commercial FDA clearance (Jun 2024), demonstrating rapid scaling from clinical trials to multi-site deployment.
- **2026-04-01** — [From Automated Surgery to Humanoid Robot Surgical Teams](https://www.nasonline.org/event/distinctive-voices-the-next-generation-of-surgery-from-automated-surgery-to-humanoid-robot-surgical-teams/) (conference-talk)
  National Academy of Sciences Distinctive Voices lecture explicitly states 'autonomous surgery is no longer science fiction' and that 'semi-autonomous robots perform surgery,' representing institutional mainstream recognition of field maturation.
- **2026-03-19** — [FDA Flags Safety Concern Over Intuitive Surgical Stapler](https://www.benzinga.com/news/fda/26/03/51363001/fda-flags-safety-concern-over-intuitive-surgical-stapler) (news-coverage)
  FDA early alert on da Vinci SureForm 30 stapler malfunction causing incomplete staple formation with 4 injuries and 1 death reported as of Feb 2026, demonstrating critical safety barriers in production deployment independent of autonomous functionality.
- **2026-03-19** — [SutureAgent: Learning Surgical Trajectories via Goal-conditioned Offline RL in Pixel Space](https://arxiv.org/abs/2603.26720) (research-paper)
  Novel ML framework for autonomous surgical suturing trajectory prediction trained on 1,158 trajectories from 50 patients showing 58.6% error reduction over baselines, demonstrating practical progress in core semi-autonomous task execution.
- **2026-03-17** — [Seger Surgical Solutions achieves milestone with successful human trials of laparoscopic bowel closure device](https://www.prnewswire.com/news-releases/seger-surgical-solutions-achieves-milestone-with-successful-human-trials-of-laparoscopic-bowel-closure-device-302714507.html) (press-release)
  Seger Surgical's first-in-human semi-autonomous intracorporeal anastomosis device completed 3 successful procedures with 100% success rate and <2 minute closure time versus 15-20 minutes manual, demonstrating emerging commercial deployments beyond Moon Surgical Maestro.
- **2026-03-05** — [AI in the Operating Room: Promise, Peril, and the Regulation Gap](https://insights.wchsb.com/2026/03/05/ai-in-the-operating-room-promise-peril-and-the-regulation-gap/) (opinion)
  Critical analysis documenting 14-fold increase in adverse events after AI integration in surgical guidance systems (Acclarent case study) and revealing that <2% of 1,357 FDA-authorized AI-enabled medical devices had supporting randomized trials, exposing regulatory and safety barriers.
- **2026-03-03** — [AI is enabling robots to assist in surgery. What to know](https://healthjournalism.org/blog/2025/09/ai-is-enabling-robots-to-assist-in-surgery-what-to-know/) (news-coverage)
  Health journalism synthesis covering autonomous examples: SRT-H 100% accuracy on 8 ex vivo procedures, Chile autonomous camera control during solo gallbladder removal, Hong Kong 3-hand system clipping blood vessels, and meta-analysis showing 25% OR time reduction and 30% complication decrease.
- **2026-03-02** — [CHU de Rouen déploie le système Maestro de Moon Surgical](https://www.lagazettefrance.fr/article/chu-de-rouen-premiere-nationale-avec-le-robot-chirurgical-maestro-de-moon-surgical) (case-study)
  CHU de Rouen became first French university hospital to adopt Maestro semi-autonomous system (February 3, 2026), demonstrating expansion of dedicated semi-autonomous platforms beyond commercial pilots into major teaching institutions.
- **2026-03-02** — [Will robots cut need for surgeons? - China robotic surgery deployment analysis](https://en-cyd.youth.cn/news/202603/t20260302_808673.htm) (news-coverage)
  Investigative journalism documenting 12,000+ robotic surgeries and 800 remote 5G-enabled surgeries in China with real-world adoption barriers: automation bias, patient/family uncertainty, and physician struggle with deferred decision-making in ostensibly autonomous systems.
- **2026-02-26** — [Chirurgie innovante : le CHU de Rouen est le 1er de France à adopter le système robotisé Maestro](https://www.rouennormandyinvest.com/actualites/chirurgie-innovante-le-chu-de-rouen-est-le-1er-de-france-a-adopter-le-systeme-robotise-maestro/) (case-study)
  CHU de Rouen became first French university hospital to adopt Moon Surgical's Maestro semi-autonomous system, with first procedure on February 3, 2026—demonstrating institutional adoption expanding across European teaching hospitals.
- **2026-02-25** — [FDA Recall Cluster Hits Minimally Invasive Surgery](https://www.statsurgicalsupply.com/news/17-recall-wave-hits-minimally-invasive-surgery-olympus-insufflation-pull-da-vinci-5-correction-raise-or-readiness-stakes) (news-coverage)
  Class II FDA recall issued February 2026 for da Vinci 5 console assembly software configuration issues, demonstrating ongoing reliability concerns impacting facility workflows and constraining platform adoption momentum.
- **2026-02-09** — [Amy J. Reed Collaborative Petitions FDA for Class I Recall of da Vinci](https://law.northeastern.edu/ajrc-petitions-fda-for-recall-of-da-vinci-surgical-systems/) (opinion)
  Northeastern University medical device safety group petitioned FDA for immediate Class I recall of da Vinci 5 due to intraoperative power failures, highlighting unresolved platform reliability barriers constraining autonomous deployment.
- **2026-02-04** — [Training And Capacity Building In Global Surgical Robotics Integration](https://www.facs.org/for-medical-professionals/news-publications/news-and-articles/bulletin/2026/february-2026-volume-111-issue-2/robotics-integration-is-transforming-global-surgical-care/) (industry-report)
  American College of Surgeons bulletin documents global robotic surgery adoption at 5% of US procedures, 2% in Europe, advancing institutional integration of AI-enabled robotic platforms across geographies.
- **2026-02-02** — [Intuitive cancels the MoU and reverts to existing agreements](https://surgicalscience.com/news/intuitive-cancels-the-mou-and-reverts-to-existing-agreements-surgical-science-estimates-that-this-will-have-a-negative-impact-on-license-revenues-of-around-sek-60-90-million-in-2026-compared-to-2025/) (press-release)
  Intuitive Surgical cancelled MOU with Surgical Science for software integration into da Vinci 5 platforms, reverting to selective deployment—signaling strategic shift in ecosystem maturation and adoption velocity constraints.
- **2026-01-28** — [The Art of Surgery in Our Automated Age: Why a Surgeon Will Always Be Necessary](https://pubmed.ncbi.nlm.nih.gov/41616876/) (opinion)
  Editorial in Journal of Arthroplasty argues for enduring surgeon role amid automation, providing critical perspective on limits of autonomous systems despite technical advances.
- **2026-01-26** — [FDA Clears Intuitive Surgical's Da Vinci 5 System for Cardiac Procedures](https://www.sahmcapital.com/news/content/fda-clears-intuitive-surgicals-da-vinci-5-system-for-cardiac-procedures-2026-01-26) (product-ga)
  FDA 510(k) clearance for da Vinci 5 expanded to cardiac indications (valve repair, ASP closure, IMA mobilization, etc.), expanding mainstream platform applicability and infrastructure for semi-autonomous feature integration.
- **2026-01-25** — [Safety and feasibility of solo surgery using a novel robotic assistant](https://pubmed.ncbi.nlm.nih.gov/41083613/) (case-study)
  IDEAL 2a multi-center observational study of Moon Surgical's Maestro semi-autonomous platform for solo abdominal surgery across 45 procedures—zero device-related adverse events with 40% procedure conversion rate and robust safety profile.
- **2026-01-16** — [Intuitive says general surgery, acute care fuel US robot momentum](https://www.medtechdive.com/news/Intuitive-Q4-general-surgery-acute-care-da-Vinci-robot-2026-outlook/809847/) (adoption-metric)
  Q4 2025 earnings report showing 1,200 da Vinci 5 systems installed globally, 270,000 procedures performed, and 11% higher utilization than Xi model—confirming accelerated adoption of AI-enabled mainstream surgical robotics platform.
- **2026-01-08** — [Anne Osdoit, CEO de Moon Surgical](https://www.agipi.com/actualites/anne-osdoit-ceo-de-moon-surgical/) (press-release)
  CEO interview reporting Maestro semi-autonomous platform deployed in 2,200+ patients worldwide with FDA clearance for iterative AI updates (March 2025), advancing commercial scale beyond initial clinical trials.
- **2026-01-07** — [AI Avalanche Is Forcing Healthcare to Reimagine Future of Surgery](https://www.facs.org/for-medical-professionals/news-publications/news-and-articles/bulletin/2026/january-2026-volume-111-issue-1/ai-avalanche-is-forcing-healthcare-to-reimagine-future-of-surgery/) (news-coverage)
  American College of Surgeons bulletin article discussing AI integration in surgery, citing autonomous gallbladder removal (July 2025) and intercontinental robotic cardiac telesurgery as pivotal advancements while raising governance questions.
- **2025-12-22** — [FDA da Vinci 5 recall and SP general surgery expansion signal mixed progress](https://ts2.tech/en/intuitive-surgical-stock-isrg-week-ahead-fda-da-vinci-5-recall-posting-da-vinci-sp-expansion-and-fresh-wall-street-targets-into-the-christmas-trading-week/) (news-coverage)
  December 2025 regulatory updates: Class 2 FDA recall (144 units) for da Vinci 5 Surgeon Console connector issue and FDA expansion of da Vinci SP to general surgery (hernia, cholecystectomy, appendectomy), providing simultaneous signals of reliability concerns and procedure category expansion.
- **2025-11-25** — [Beyond precision: why time and human judgment still matter in autonomous surgery](https://pmc.ncbi.nlm.nih.gov/articles/PMC12690314/) (opinion)
  Peer-reviewed commentary references SRT-H system achieving 100% autonomous cholecystectomy task success but argues that technical advancement doesn't guarantee clinical readiness; emphasizes human factors, situational awareness gaps, and practical barriers constraining autonomous deployment despite capability breakthroughs.
- **2025-11-21** — [Huntsman Cancer Institute completes full fleet upgrade to da Vinci 5 with AI analytics](https://healthcare.utah.edu/huntsmancancerinstitute/press-releases/2025/11/smaller-incisions-faster-healing-future-of-cancer-surgery-here) (case-study)
  Huntsman Cancer Institute's production-scale da Vinci 5 deployment: 10 platforms across 5 operating sites with 44 active surgeons, 12,000+ cumulative procedures since 2005, and 40% reduction in tissue force applied—demonstrating real-world clinical adoption of latest AI-enabled platform.
- **2025-10-22** — [Intuitive Surgical Q3 2025 earnings: da Vinci 5 adoption accelerates](https://www.medtechdive.com/news/Intuitive-Surgical-Q3-earnings-da-Vinci-5/803497/) (adoption-metric)
  Q3 2025 earnings show 240 da Vinci 5 placements (up from 110 in Q3 2024, 118% growth) and 427 total da Vinci placements with 20% procedure growth year-over-year, confirming rapid market adoption of latest AI-enabled robotic surgical platform during Q4 window.
- **2025-10-08** — [Intuitive Surgical da Vinci systems installed base and da Vinci 5 trajectory](https://matrixbcg.com/blogs/growth-strategy/intuitive) (adoption-metric)
  Market analysis shows 10,189 da Vinci systems installed (15% YoY growth), da Vinci 5 with 2,500+ surgeons using it for 32,000+ procedures and 147 systems placed in Q1 2025, positioning platform for autonomous feature integration; company actively exploring future AI applications including autonomous suturing.
- **2025-10-01** — [Surgical Science simulation software integrated into all da Vinci 5 systems](https://surgicalscience.com/news/surgical-science-is-transitioning-to-a-fully-subscription-based-revenue-model-with-intuitive-and-all-da-vinci-5-systems-will-be-equipped-with-surgical-science-simulation-software/) (product-ga)
  Surgical Science signed letter of intent to integrate simulation software into all da Vinci 5 systems via subscription-based model (effective Jan 2025), signaling ecosystem maturation and standardization of training infrastructure supporting broader surgical robotics adoption.
- **2025-09-19** — [SutureBot: A Precision Framework for Autonomous Surgical Suturing on da Vinci Research Kit](https://neurips.cc/virtual/2025/loc/san-diego/poster/121650) (research-paper)
  NeurIPS 2025 benchmark for autonomous suturing with released dataset of 1,890 demonstrations; goal-conditioned framework improves targeting accuracy 59-74% over baseline, advancing precision in autonomous suturing research.
- **2025-07-15** — [Human-Robot collaboration in surgery: Advances and challenges towards autonomous surgical assistants](https://arxiv.org/abs/2507.11460v1) (research-paper)
  Systematic review (32 studies) accepted at 2025 IEEE ROMAN conference; identifies growing ASAR research emphasis, current strength in endoscope guidance, emerging tool manipulation advances, and persistent challenges in procedural awareness and human-robot coordination.
- **2025-07-09** — [Robotic surgery hits 'milestone' with autonomous gallbladder removal](https://www.upi.com/Health_News/2025/07/09/robotic-surgery-autonomous-gallbladder-removal/8541751908009/) (case-study)
  Johns Hopkins/Stanford SRT-H AI system successfully performed 8 ex vivo gallbladder removal procedures with 100% accuracy autonomously, demonstrating shift from task-specific execution to procedural understanding; published in Science Robotics.
- **2025-07-09** — [A robot shows that machines may one day replace human surgeons](https://english.elpais.com/science-tech/2025-07-09/a-robot-shows-that-machines-may-one-day-replace-human-surgeons.html) (news-coverage)
  Critical expert commentary on SRT-H gallbladder study emphasizes biological variability, testing on young animals without patient comorbidities, and cost barriers; reflects skepticism about near-term clinical deployment despite technical proof-of-concept.
- **2025-07-07** — [Autonomous Image-to-Grasp Robotic Suturing Using Reliability-Driven Suture Thread Reconstruction (2025 update)](https://ucsdarclab.com/autopublication/autonomous-image-to-grasp-robotic-suturing-using-reliability-driven-suture-thread-reconstruction/) (research-paper)
  Updated UCSD pipeline for autonomous suturing using reliability-driven thread reconstruction with >400 grasping trials; demonstrates state-of-the-art accuracy for autonomous suture manipulation independent of tissue properties.
- **2025-06-24** — [Moon Surgical élargit son équipe de direction pour accélérer la croissance commerciale aux États-Unis et en Europe](https://www.prnewswire.com/fr/communiques-de-presse/moon-surgical-elargit-son-equipe-de-direction-pour-accelerer-la-croissance-commerciale-aux-etats-unis-et-en-europe-302490282.html) (press-release)
  Moon Surgical reports Maestro semi-autonomous system deployed in 1,600+ procedures worldwide with 1,400 in past year across 60 surgical types, demonstrating rapid acceleration of dedicated semi-autonomous platform adoption in Q2 2025.
- **2025-06-16** — [Q&A: Moon Surgical's Maestro System and assisting in laparoscopic surgery](https://www.mobihealthnews.com/news/qa-moon-surgicals-maestro-system-and-assisting-laparoscopic-surgery) (news-coverage)
  Moon Surgical CEO interview confirms Maestro semi-autonomous system used in 60+ patients in U.S. and Europe, second-generation deployed in France with AI integration for setup automation and vision control advancing commercial deployment.
- **2025-05-31** — [Accuracy and safety of implant placement with a novel semi-autonomous robotic-assisted surgical system: A translational research study](https://pubmed.ncbi.nlm.nih.gov/39580315/) (research-paper)
  Translational study of semi-autonomous robotic system for dental implant placement across models, animals, and 60 human participants demonstrated significantly lower angular deviation (3.1° vs 7.9°, p<.001) and superior accuracy with zero complications.
- **2025-05-25** — [Preparing for the Rise of Autonomous Surgery](https://healthmanagement.org/c/it/News/preparing-for-the-rise-of-autonomous-surgery) (opinion)
  Industry analysis projects global autonomous surgical robotics market to exceed €10 billion by 2033; identifies regulatory frameworks as primary bottleneck and emphasizes that AI maturation is accelerating progress toward autonomous surgery implementation.
- **2025-04-01** — [Legal and Forensic Implications in Robotic Surgery](https://www.clinicaterapeutica.it/ojs/index.php/1/article/view/1188) (opinion)
  Academic review identifies inadequate regulatory frameworks, liability ambiguity, and missing informed consent standards as critical barriers to autonomous robotic surgery deployment, reinforcing governance challenges constraining adoption beyond research settings.
- **2025-03-28** — [Autonomous Suturing in Robotic Surgery Using Reinforcement Learning and 3D Vision](https://jneonatalsurg.com/index.php/jns/article/view/2754) (research-paper)
  Reinforcement learning framework for autonomous robotic suturing with 3D vision achieved higher accuracy than teleoperation on synthetic tissue models, advancing autonomous suturing feasibility through improved trajectory optimization and tissue deformation handling.
- **2025-03-18** — [Intuitive Surgical (ISRG): da Vinci 5 Recall and Growth](https://www.monexa.ai/blog/intuitive-surgical-isrg-da-vinci-5-recall-and-grow-ISRG-2025-03-18) (news-coverage)
  Class 2 FDA recall of da Vinci 5 (faulty foot pedal, 439 units affected) revealed platform-level reliability issues mid-2025 rollout, reinforcing safety and liability barriers constraining adoption of autonomous features despite technical advances.
- **2025-01-29** — [4 robotic surgery trends to watch in 2025](https://www.medtechdive.com/news/Robotic-surgery-outlook-2025-Intuitive-Surgical-Medtronic/738468/) (news-coverage)
  Market analysis shows da Vinci 5 launch exceeding expectations with 2,500+ surgeons, 40+ procedure types, and 493 units placed in Q4 2024, demonstrating broad platform adoption creating foundation for autonomous feature integration at scale.
- **2025-01-07** — [New AI Research Foreshadows Autonomous Robotic Surgery](https://developer.nvidia.com/blog/new-ai-research-foreshadows-autonomous-robotic-surgery/) (research-paper)
  Vision-language model integrated with da Vinci robot achieved zero-shot imitation learning from 20 hours of surgical video, autonomously performing tissue lifting, needle use, and suturing with problem-solving capability, advancing practical autonomous surgical task execution.
- **2024-11-14** — [Moon Surgical completes first-in-human clinical study of Maestro surgical robotics system](https://www.boerse-express.com/news/articles/moon-surgical-schliesst-seine-klinische-first-in-human-studie-zu-seinem-maestrotm-surgical-robotics-system-ab-531692) (case-study)
  Moon Surgical reports successful completion of first-in-human clinical study with 30 laparoscopic procedures using Maestro semi-autonomous system at CHU Saint-Pierre teaching hospital, validating clinical safety and efficacy of dedicated semi-autonomous platform.
- **2024-11-11** — [Robot that watched surgery videos performs with skill of human doctor](https://hub.jhu.edu/2024/11/11/surgery-robots-trained-with-videos/) (research-paper)
  Johns Hopkins demonstrates imitation learning training surgical robots from video of seasoned surgeons, achieving human-equivalent performance on complex procedures—eliminating manual programming and advancing true autonomy where robots perform surgeries without human help.
- **2024-11-07** — [AI brings autonomous procedures closer, but surgeons still key](https://hub.jhu.edu/2024/11/07/autonomous-robotic-surgery-briefing/) (opinion)
  Johns Hopkins robotics panel acknowledges AI advances toward autonomous surgery but emphasizes complementary human-machine capabilities and surgeon oversight, reflecting expert consensus that partnership rather than full replacement remains realistic near-term pathway.
- **2024-10-09** — [Regulatory Challenges in AI-Powered Medical Robotics Adoption](https://pmarketresearch.com/it/ai-in-medical-robotics-market/) (industry-report)
  Market analysis documents regulatory divergence between FDA's SaMD pathway and EU Medical Device Regulation for AI-enabled surgical robots, identifying harmonization barriers and post-market surveillance requirements constraining international autonomous system deployment.
- **2024-09-24** — [Quest to develop fully autonomous surgical robot attracts award up to $12M from ARPA-H](https://engineering.vanderbilt.edu/2024/09/24/quest-to-develop-fully-autonomous-surgical-robot-attracts-award-up-to-12-million-from-arpa-h/) (research-paper)
  ARPA-H awards up to $12M to multi-institution consortium (Vanderbilt, Utah, Johns Hopkins) for developing fully autonomous surgical robot for tumor removal with 3-year demonstration goal in simulated conditions, signaling major institutional commitment to autonomous surgery development.
- **2024-09-06** — [Evaluating Autonomous Data-Driven Robotic Needle Steering for MRI-Guided Prostate Procedures](https://pmc.ncbi.nlm.nih.gov/articles/PMC11448709/) (research-paper)
  Research demonstrates autonomous data-driven robotic needle steering for MRI-guided prostate procedures using parameter-agnostic trajectory correction and closed-loop shape sensing, advancing autonomous execution in critical clinical tasks.
- **2024-08-29** — [Autonomous Image-to-Grasp Robotic Suturing Using Reliability-Driven Suture Thread Reconstruction](https://arxiv.org/abs/2408.16938) (research-paper)
  Research from UC San Diego presents autonomous image-to-grasp robotic suturing pipeline with over 400 grasping trials demonstrating state-of-the-art accuracy for autonomous suture thread manipulation and grasping, advancing feasibility of core autonomous surgical subtask.
- **2024-08-11** — [Autonomy in Robotics Surgery: State of the art, technical and regulatory challenges for clinical application](https://metropolis.scienze.univr.it/icra24-workshop-autonomy-in-robotics-surgery/) (conference-talk)
  ICRA 2024 full-day workshop convened leading experts to address regulatory frameworks (EU AI Act), technical integration pathways, and clinical roadmaps for autonomous surgical robots, reflecting mainstream academic and industry engagement with autonomy implementation challenges.
- **2024-08-01** — [Intuitive Surgical in artificial intelligence: Theme innovation strategy](https://www.medicaldevice-network.com/data-insights/intuitive-surgical-in-artificial-intelligence-theme-innovation-strategy/) (industry-report)
  Analysis of Intuitive Surgical's Q2 2024 AI patenting strategy shows focus on autonomous determination of surgical procedure stages with context-relevant assistance, demonstrating market leader R&D investment in autonomy features for mainstream robotic platforms.
- **2024-07-16** — [Novanta announce winners of SRT Awards 2024](https://novanta.com/news/novanta-announce-winners-of-srt-awards-2024/) (industry-report)
  Surgical Robotics Industry Awards highlight Moon Surgical's Maestro System in commercial use across multiple hospitals with 250+ patients treated, and MMI's Symani System receiving FDA De Novo clearance (April 2024) for reconstructive microsurgery, demonstrating market advancement in semi-autonomous and precision robotics.
- **2024-05-09** — [The current state of autonomous suturing: a systematic review](https://www.springermedicine.com/the-current-state-of-autonomous-suturing-a-systematic-review/26921538) (research-paper)
  Surgical Endoscopy review of 41 autonomous suturing articles (81% post-2014) found significant technological advances in knot-tying and needle insertion subtasks, with 76% of research in engineering journals, confirming sustained academic interest and feasibility progress in autonomous suturing.
- **2024-04-26** — [Levels of autonomy in FDA-cleared surgical robots: a systematic review](https://pubmed.ncbi.nlm.nih.gov/38671232/) (industry-report)
  NPJ Digital Medicine systematic review of 49 FDA-cleared surgical robots (2015-2023) found 86% at Level 1 autonomy, 6% at Level 3, and only 2 with ML-enabled capabilities, revealing regulatory frameworks lag technical autonomy trends and identifying gaps in formal autonomy classification.
- **2024-04-04** — [Robotic Surgery Errors to Watch Out for In 2024](https://www.rbrlaw.com/blog/2024/april/robotic-surgery-errors-to-watch-out-for-in-2024/) (opinion)
  Legal analysis identifies mechanical failures (arm calibration, instrument failure), software glitches, and programming errors as common robotic surgery complications, noting that surgeon expertise is critical to anticipating and mitigating system failures—highlighting ongoing reliability risks.
- **2024-03-19** — [Moon Surgical's Maestro System Treats Over 200 Patients in Commercial Deployment](https://www.prnewswire.com/fr/communiques-de-presse/le-systeme-maestro-de-moon-surgical-propulse-par-nvidia-holoscan-ouvre-la-voie-a-la-laparoscopie-de-nouvelle-generation-avec-plus-de-200-patients-traites-302092850.html) (case-study)
  Moon Surgical reports Maestro semi-autonomous laparoscopic system in commercial use across 2 French hospitals with 200+ patients treated by 10+ surgeons, demonstrating scale-up from clinical trial to multi-site deployment with AI-powered ScoPilot autonomy.
- **2024-03-14** — [FDA Clears Intuitive Surgical's da Vinci 5 Robotic Surgical System](https://www.sec.gov/Archives/edgar/data/1035267/000103526724000125/q124ex-991dv5fdaclearancex.htm) (product-ga)
  SEC 8-K filing documents FDA 510(k) clearance of da Vinci 5 with >10,000x computing power of Xi enabling AI integration, force feedback reducing tissue trauma by 43%, and autonomy features advancing semi-autonomous deployment.
- **2024-02-12** — [Surgical Robot Burns Patient's Intestine Causing Death — Lawsuit](https://www.tampabay.com/news/health/2024/02/12/da-vinci-surgical-robot-intuitive-surgical-inc-palm-beach-county/) (news-coverage)
  Tampa Bay Times reports federal lawsuit alleging da Vinci robot caused fatal injury via electrical arc during colon surgery, highlighting platform safety risks and liability concerns that constrain autonomous system adoption and surgeon acceptance.
- **2023-11-08** — [Adaptive Human-Robotic Interaction for Robotic-assisted Surgical Operations](https://pubmed.ncbi.nlm.nih.gov/37948270/) (research-paper)
  Purdue University study evaluates mental workload-based adaptive automation for semi-autonomous suction assistance, achieving 77.9% workload classification accuracy and demonstrating feasibility of reducing surgeon cognitive load.
- **2023-10-01** — [Development and Evaluation of a Single-arm Robotic System for Autonomous Suturing](https://pure.johnshopkins.edu/en/publications/development-and-evaluation-of-a-single-arm-robotic-system-for-aut/) (research-paper)
  Johns Hopkins STAR robot demonstrates single-arm autonomous suturing with suture management at 29.1 seconds per stitch, advancing toward autonomous anastomosis by reducing system complexity from dual-arm to single-arm architecture.
- **2023-09-01** — [Intuitive Surgical Annual Report 2023](https://quarterlytics.com/company/intuitive-surgical_isrg/annual-report-2023/) (adoption-metric)
  Intuitive Surgical 2023 adoption metrics show 14 million cumulative da Vinci procedures (22% growth in 2023), over 9,100 installed systems, and >2.2 million procedures annually, confirming sustained platform adoption underpinning semi-autonomous integration efforts.
- **2023-07-14** — [Autonomous Soft Tissue Retraction Using Reinforcement Learning with DaVinci in Simulation](https://ar5iv.labs.arxiv.org/html/2309.00837) (research-paper)
  Georgia Tech MICCAI 2023 workshop paper demonstrates demonstration-guided reinforcement learning for autonomous soft tissue retraction on da Vinci in simulation, validating feasibility of autonomous exposure task.
- **2023-07-13** — [Self-Supervised Learning for Interactive Perception of Surgical Thread for Autonomous Suture Tail-Shortening](http://arxiv.org/abs/2307.06845) (research-paper)
  UC Berkeley/CASE 2023 paper presents self-supervised learning for autonomous suture tail-shortening with 90% success rate across 20 trials, advancing autonomous thread manipulation as key surgical subtask.
- **2023-07-01** — [Autonomous System for Vaginal Cuff Closure via Model-Based Planning and Markerless Tissue Tracking](https://pure.johnshopkins.edu/en/publications/autonomous-system-for-vaginal-cuff-closure-via-model-based-planni/) (research-paper)
  IEEE Robotics and Automation Letters study shows STAR robot achieves superior vaginal cuff closure accuracy and consistency versus human surgeons on synthetic tissue, advancing autonomous execution of complete surgical procedures.
- **2023-04-12** — [Maestro Surgical Robotics System by Moon Surgical, Now CE Marked](https://sofinnovapartners.com/news/maestro-surgical-robotics-system-by-moon-surgical-now-ce-marked) (press-release)
  Moon Surgical's Maestro semi-autonomous laparoscopic system achieved CE Mark regulatory approval with 50-patient clinical trial in Europe, demonstrating clinical-stage deployment of semi-autonomous surgical assistance technology.
- **2023-03-15** — [Field corrective actions - Urgent Field Safety Notice for da Vinci Xi and da Vinci X Surgical System by Intuitive Surgical, Inc](https://www.bfarm.de/SharedDocs/Kundeninfos/EN/12/2023/07009-23_kundeninfo_en.html) (news-coverage)
  German regulatory agency safety notice on da Vinci surgical systems indicates platform-level device safety issues and corrective actions, reinforcing reliability barriers that constrain autonomous system integration and adoption.
- **2022-11-23** — [New Robotic System with Wristed Microinstruments Allows Precise Reconstructive Microsurgery: Preclinical Study](https://pubmed.ncbi.nlm.nih.gov/35727461/) (research-paper)
  Randomized controlled preclinical trial in Annals of Surgical Oncology shows new robotic system achieves statistically significant improvements in suture precision (p=0.02 distance, p<0.01 angulation) versus manual techniques, advancing microsurgical capability.
- **2022-10-04** — [Open-source High-precision Autonomous Suturing Framework With Visual Guidance](https://arxiv.org/abs/2210.01406v1) (research-paper)
  Academic research framework for autonomous suturing ranked first in AccelNet Surgical Robotics Challenge, demonstrating algorithmic progress in needle pose estimation and trajectory planning for autonomous surgical tasks.
- **2022-09-23** — [Challenges of deep learning and autonomous actions in surgery](https://www.oaepublish.com/articles/ais.2022.11) (research-paper)
  Systematic review in Artificial Intelligence Surgery identifies technical, ethical, and clinical barriers to autonomous surgery including high computational requirements, annotated data scarcity, and surgeon knowledge gaps in AI concepts.
- **2022-09-16** — [Autonomous surgical robotic systems and the liability dilemma](https://www.frontiersin.org/journals/surgery/articles/10.3389/fsurg.2022.1015367/full) (research-paper)
  iRobotSurgeon survey of 2,191 respondents across 78 countries reveals liability and blame allocation barriers: participants blame surgeons less as robotic autonomy increases, yet still assign blame in fully autonomous scenarios, highlighting regulatory uncertainties.
- **2022-07-01** — [Concepts and Trends in Autonomy for Robot-Assisted Surgery](https://pure.johnshopkins.edu/en/publications/concepts-and-trends-in-autonomy-for-robot-assisted-surgery/) (research-paper)
  Johns Hopkins review in Proceedings of the IEEE surveys autonomy trends in surgical robotics, noting over 4,000 telerobots in daily use and research focus on introducing surgeon-assist autonomy to reduce tedium and improve consistency.
- **2022-06-01** — [White paper: definitions of artificial intelligence and autonomous actions in clinical surgery](https://www.oaepublish.com/articles/ais.2022.10) (industry-report)
  Expert consensus definitions from Artificial Intelligence Surgery journal establish standardized terminology for AI and autonomy in surgery, signaling community maturation as autonomous systems develop.
- **2022-05-12** — [Medical malpractice in robotic surgery: a Westlaw legal database review](https://pmc.ncbi.nlm.nih.gov/articles/PMC9097886/) (research-paper)
  Legal analysis of malpractice claims in robotic surgery identifies significant liability and safety barriers that inform regulatory risk for autonomous systems, constraining adoption trajectory.
- **2022-04-13** — [A systematic review of robotic surgery: From supervised to fully autonomous robotic surgical systems](https://pubmed.ncbi.nlm.nih.gov/34953033/) (research-paper)
  Systematic review of 51 articles confirms that while fully automated systems remain conceptual, supervised autonomous robotic systems are actively researched but face significant ethico-legal hurdles.
- **2022-03-16** — [A neurotechnological aid for semi-autonomous suction in robotic-assisted surgery](https://pubmed.ncbi.nlm.nih.gov/35296714/) (research-paper)
  Purdue research demonstrates semi-autonomous suction assistance using EEG-based cognitive workload assessment, showing 80% accuracy in detecting surgeon demand states and potential for improved collaboration.
- **2022-02-23** — [Malfunction Events in the US FDA MAUDE Database](https://pubmed.ncbi.nlm.nih.gov/34464761/) (research-paper)
  Analysis of 679 da Vinci robot malfunction reports shows 84.5% instrument malfunction rates and 15.6% patient injury rates, revealing critical platform reliability and safety gaps that constrain autonomous system adoption.
- **2022-01-26** — [Robot performs first laparoscopic surgery without human help](https://hub.jhu.edu/2022/01/26/star-robot-performs-intestinal-surgery/) (case-study)
  Johns Hopkins STAR robot autonomously performed intestinal anastomosis on pig tissues with superior results to human surgeons, demonstrating a significant step toward fully automated surgery.
- **2021-11-18** — [Surgical Robot Transformer (SRT): Imitation Learning for Autonomous Surgical Manipulation](https://arxiv.org/html/2407.12998v1) (research-paper)
  Johns Hopkins and Stanford research demonstrates imitation learning enabling autonomous surgical tasks on da Vinci platform—tissue manipulation, needle handling, knot-tying—advancing ML-driven autonomous surgical capabilities.
- **2021-11-14** — [A systematic review on artificial intelligence in robot-assisted surgery](https://pubmed.ncbi.nlm.nih.gov/34695601/) (research-paper)
  Analysis of 35 AI publications finds low quality evidence and small datasets; concludes there is no proof AI can identify critical tasks determining patient outcomes, revealing maturity gaps in AI-assisted surgical systems.
- **2021-07-07** — [Rethinking Autonomous Surgery: Focusing on Enhancement over Autonomy](https://pubmed.ncbi.nlm.nih.gov/34246619/) (opinion)
  Critical review from UT Southwestern argues for collaborative enhancement over full autonomy, noting research found no studies evaluating semi-autonomy effects on patient outcomes, highlighting evidence gaps.
- **2021-07-02** — [Breaking Barriers in Robotic Soft Tissue Surgery: Conditional Autonomous Intestinal Anastomosis](http://arxiv.org/abs/2107.01288) (research-paper)
  First in vivo autonomous robotic laparoscopic surgery via intestinal anastomosis on porcine models, achieving level 3 autonomy with superior consistency and accuracy compared to human surgeons and manual laparoscopic techniques.
- **2021-02-26** — [Autonomous Robotics for Transcatheter Cardiac Procedures (ARTERY)](https://clinicaltrials.gov/study/NCT04787757) (research-paper)
  Clinical trial registration indicating planned human clinical evaluation of semi-autonomous surgical systems for cardiac interventions, marking progression from preclinical research to human testing.
- **2021-02-24** — [Hey Siri! Perform a type 3 hysterectomy. Please watch out for the ureter: What is autonomous surgery and what are the latest developments?](https://jtgga.org/articles/hey-siri-perform-a-type-3-hysterectomy-please-watch-out-for-the-ureter-what-is-autonomous-surgery-and-what-are-the-latest-developments/jtgga.galenos.2021.2020.0187) (opinion)
  Review article notes that while fully autonomous systems remain distant, partially autonomous systems have gradually entered clinical use, with investments from Intuitive Surgical, Google, Verb Surgical, and others.
- **2020-11-14** — [Autonomous surgery in the era of robotic urology: friend or foe of the future surgeon?](https://pubmed.ncbi.nlm.nih.gov/32968240/) (research-paper)
  Nature Reviews Urology reports first clinical trial data on autonomous robotic-assisted surgery in urology being published, marking the emergence of autonomous surgical capabilities from preclinical research into clinical evaluation.
- **2020-10-16** — [Autonomous Tissue Retraction in Robotic Assisted Minimally Invasive Surgery](https://research.manchester.ac.uk/en/publications/autonomous-tissue-retraction-in-robotic-assisted-minimally-invasi/) (research-paper)
  IEEE paper presents semi-autonomous tissue retraction using deep neural networks and procedural algorithms, achieving 25% visibility improvement on DaVinci Research Kit, demonstrating progress toward autonomous execution of fundamental surgical tasks.
- **2020-05-15** — [Clinical Desire for an Artificial Intelligence–Based Surgical Assistant System](https://medinform.jmir.org/2020/5/e17647/) (research-paper)
  Survey of 508 surgeons shows 83.3% willing to adopt AI-based autonomous surgical assistant systems and 40% believe such systems could substitute 41-60% of current workforce, indicating strong clinical interest in autonomous surgical capabilities.
- **2020-04-30** — [Complications of Robotic Surgery](https://pubmed.ncbi.nlm.nih.gov/32169190/) (research-paper)
  Comprehensive review in Surgical Clinics of North America documenting complications across robotic-assisted procedures, showing that despite revolutionary impact, systems are 'not exempt from complications,' providing critical assessment of maturity challenges.
- **2020-02-03** — [Toward Autonomous Robotic Micro-Suturing using Optical Coherence Tomography Calibration and Path Planning](https://arxiv.org/abs/2002.00530v1) (research-paper)
  ICRA 2020 paper demonstrates autonomous suturing system achieving 0.27mm accuracy in tissue phantoms using deep learning-based tissue detection and path planning, advancing technical feasibility of autonomous micro-surgical tasks.

## History

- **2026-Sep:** Lab evidence advanced: an occupancy-network system completed 8 consecutive margin-negative nephrectomy resections in phantoms, and MACAW reached 93% success at 304 fragments/hour in 100 physical debridement trials on the dVRK, both beating prior baselines but confined to phantoms and bench setups. Independent reviews counter that no autonomous procedure has been performed in a human, spinal and brachytherapy task autonomy remain research-only, and a UAE survey found public trust in machine autonomy still a real adoption barrier.
- **2026-Aug:** A newly published independent DEPLOY registry catalogued 52 commercial semi-autonomous deployments across 47 companies alongside 24 documented safety incidents, and ecosystem breadth widened further as Endorobotics' ROBOPERA won FDA 510(k) clearance for endoscopic surgical automation with an exclusive Olympus distribution deal, and Moon Surgical reported SRS 2026 data showing Maestro reduced procedural-time variability in sleeve gastrectomy. Andromeda Surgical raised a $15M Series A ($30M total) for its Beacon semi-autonomous HoLEP platform with an active 54-patient ASTRA trial, and UC San Diego researchers demonstrated teleoperated humanoid laparoscopic gallbladder removal in a preclinical feasibility study, though trade press flagged latency and recalibration issues. A dual-arm VLA subtask-manipulation study showed adaptive execution lifting needle- and tissue-manipulation success rates by 5-25 points, and a structured-light depth-reconstruction method reached 26 Hz real-time laparoscopic guidance at 3.7mm accuracy. Countervailing signals sharpened: Vicarious Surgical liquidated after roughly $300M in pre-clinical spend with zero patients treated, GLP-1 medications are cutting da Vinci bariatric procedure volumes, fewer than 10% of emerging-market hospitals can afford advanced robotic platforms (a Johns Hopkins perspective cited a 6,087-to-541 US-vs-rest-of-world installed-base gap), a 2024 FDA systematic review found 86% of cleared surgical robots remain at Level 1 (continuous surgeon control) versus 6% at Level 3, and a documented 2022 fatal vascular-perforation case in robotic-assisted prostatectomy underscored ongoing liability stakes. Late-August analysis sharpened the roadmap-vs-reality gap: an audit of Intuitive's five-layer AI roadmap found only two of five layers actually shipped, a competitive-landscape review noted Intuitive's 11,710-system installed base is now genuinely contested (J&J OTTAVA FDA De Novo, Medtronic Hugo commercial launch, MicroPort Toumai overtaking da Vinci unit share in China), and FDA proposed a two-axis (clinical-significance x autonomy) risk framework for GenAI surgical devices. Deployment and validation signals mixed: Profound Medical's TULSA-PRO reached "supervised robotic autonomy" in production (4 procedures/day, FDA-cleared in 7 markets), Tuodao Medical completed human force-feedback laparoscopic surgery over 2,400km, and Catalonia reported a sevenfold regional adoption surge (1,288 to 9,402 procedures since 2018); but a systematic review found only 3 of 1,357 FDA-cleared AI medical devices had been evaluated on patient outcomes, underscoring the persistent validation gap.
- **2026-Jul:** Humanoid surgical platforms advanced on two fronts: Johns Hopkins demonstrated genuine adaptive autonomy (180 micro-decisions/minute, autonomous cautery to control arterial bleeding) in porcine gallbladder removals with an IDE application planned for Q4 2026, while a teleoperated Unitree G1 humanoid completed live porcine cholecystectomy in a Nature-published feasibility study — but the same hardware was flagged by the Pentagon as Chinese military technology carrying a wormable security exploit, complicating its clinical pathway. A peer-reviewed IEEE paper solved a key kinematic-uncertainty problem for cable-driven RCM manipulators, and analysts documented 4 research groups and 3 vendors now fielding AI copilot prototypes (35% of new surgical robot installs AI-enabled). CMS established a reimbursement pathway for algorithm-driven care and HHS identified trust/governance infrastructure — not regulatory speed or technology maturity — as the primary adoption barrier, while a 949,507-patient registry study found robotic-assisted bariatric surgery carries higher serious-adverse-event risk than laparoscopy.
- **2026-Jun:** Ecosystem diversification accelerated alongside sharpened governance and robustness concerns. LEM Surgical's Dynamis dual-arm humanoid system received a second FDA 510(k) clearance for continuous multi-vertebra tracking and bilateral workflow, while Shanghai MicroPort's Toumai gained CE marking backed by a landmark 2,400 km remote prostatectomy (London-Gibraltar via 5G). ForSight Robotics' JASPER achieved world-first fully robot-assisted cataract surgery, extending semi-autonomous execution into ophthalmology. The SAGES professional society identified current regulatory and legal frameworks as inadequate, formalizing a tripartite risk framework (AI system, clinician, institutional) and affirming human-in-the-loop supervision as the near-term prerequisite. Technical robustness limits were quantified: UC Berkeley/Stanford research found learned surgical policies suffer 61% success-rate reduction under imperceptible adversarial perturbations, and ICRA 2026 work confirmed kinematic inaccuracy in surgical robots remains a primary control barrier requiring vision-based learned feedback. Class I FDA recalls of da Vinci systems (incomplete staple lines, arm screw breakage) and a JAMA Surgery finding of higher bile duct injury rates with robotic-assisted cholecystectomy reinforced that governance and reliability barriers remain unresolved despite expanding deployment signals.
- **2026-May:** Technical trajectory and governance frameworks crystallized alongside new commercial deployment signals. King's College London forecast surgical robotics shifting toward autonomous systems with human-in-the-loop control; Johns Hopkins' H. Russell Taylor proposed hybrid AI plus patient-specific digital twins as the near-term architecture. J&J's OTTAVA completed a 30-patient gastric-bypass trial with 100% autonomous procedure completion and no manual conversions, then filed FDA De Novo application for multi-procedure general surgery — the clearest signal yet of a second major vendor entering semi-autonomous deployment. Chinese Shuairu robot CE-marked and deployed at Munich Klinik Bogenhausen (May 2026) with documented single-port lung and adrenal resections, breaking US monopoly in premium surgical robotics in Europe. Peer-reviewed evidence from 79 Maestro-assisted cholecystectomies confirmed 35% reduction in operative time variability with zero device-related complications, advancing the clinical evidence base for production semi-autonomous assistance. Critical platform safety barriers persisted: Irish HPRA issued device modification guidance for da Vinci X & Xi systems, and multiple Class II FDA recalls of da Vinci reusable instruments (broken pitch cables across several instrument types, worldwide distribution) signaled systemic quality concerns constraining autonomous feature integration momentum.
- **2026-Mar/Apr:** Institutional mainstream recognition elevated semi-autonomous surgery to national-level discourse. National Academy of Sciences Distinctive Voices lecture (April 1) explicitly stated 'autonomous surgery is no longer science fiction' and documented 'semi-autonomous robots perform surgery' with 'transformative potential.' Novel ML frameworks advanced autonomous suturing: SutureAgent (arXiv March 2026) reduced needle trajectory prediction error 58.6% on patient-derived datasets (50 patients, 1,158 trajectories), demonstrating technical progress beyond simulation. Commercial ecosystem expanded: Seger Surgical completed first-in-human semi-autonomous bowel closure (100% success, <2 min closure vs. 15-20 min manual), signaling second company entering semi-autonomous surgical deployment. Moon Surgical's ScoPilot achieved FDA clearance for autonomous camera positioning on Maestro — the first FDA-cleared AI intraoperative function running natively on a commercial surgical robot platform, with 1,100+ patients treated; Medtronic deployed Stealth AXiS with real-time autonomous vertebral tracking for complex spine fusion, extending autonomous navigation beyond laparoscopy. Competing ecosystem matured: Chinese systems (MP1000/MP2000, Edge Cloud) received NMPA regulatory clearance with reported 100% multi-specialty success rates; microsurgery robot market analysis projects 17.12% CAGR through 2031, with semi-autonomous systems as the fastest-growing segment reducing surgeon proficiency curves from 40 to 15 cases. International consensus standards for robotic stroke treatment (King's College London) assessed AI-assisted mechanical thrombectomy robotics as 'not yet ready for routine clinical use' despite hardware-level autonomy demonstrations — a meaningful check on adoption pace in vascular applications. Critical safety concerns persisted: FDA documented da Vinci curved-tip stapler failures (4 injuries, 1 death) and UK MHRA issued field safety notice for da Vinci X & Xi systems, signaling ongoing reliability constraints on incumbent platforms. Research synthesis identified regulatory gaps: critical analysis found 14-fold increase in adverse events after AI integration and <2% of 1,357 FDA-authorized AI-enabled devices supported by randomized trials, exposing barriers to autonomous surgical system maturation. Field remains at inflection point: multiple commercial platforms now deployed, institutional recognition mainstream, but platform safety and undefined regulatory frameworks continue constraining rapid scaling.
- **2026-Feb:** Institutional adoption of dedicated semi-autonomous platforms accelerated: CHU de Rouen (France) became first university hospital to adopt Moon Surgical's Maestro, with first procedure February 3, 2026, demonstrating expansion across major teaching institutions. Global adoption metrics confirmed: ACS bulletin documented 5% robotic surgery penetration in US, 2% in Europe, underpinning infrastructure for semi-autonomous feature integration. Ecosystem challenges emerged: Intuitive Surgical cancelled software integration MOU with Surgical Science on February 2, reverting to selective deployment to minority of da Vinci 5 installed base, signaling adoption velocity constraints. Critical platform safety barriers reinforced: FDA petition from Northeastern University's Amy J. Reed Collaborative (February 9) requested Class I recall of da Vinci 5 due to intraoperative power failures; Class II FDA recall issued February 25 for Surgeon Console software configuration defects. Regulatory expansion and platform reliability concerns provided simultaneous signals of market growth and unresolved safety constraints.
- **2026-Jan:** Mainstream platform regulation expanded with FDA 510(k) clearance for da Vinci 5 cardiac procedures, positioning platform for broader autonomous feature integration. Moon Surgical's Maestro achieved 2,200+ patient deployments worldwide with FDA-approved iterative AI updates, demonstrating commercial viability of dedicated semi-autonomous systems. IDEAL 2a multi-center study validated safety and feasibility of Maestro for solo abdominal surgery across 45 procedures with zero device-related adverse events, advancing clinical evidence. Platform adoption momentum continued with 1,200 da Vinci 5 systems installed (270,000 procedures globally), yet critical adoption barriers remained largely unchanged: no clinical benefit evidence, undefined liability frameworks, and ongoing platform reliability concerns constraining deployment beyond specialist centres.
- **2025-Q4:** Mainstream platform adoption accelerated with da Vinci 5 placements doubling (240 units in Q3 vs. 110 in Q3 2024); Huntsman Cancer Institute deployed full 10-system fleet with reported 40% tissue force reduction. Ecosystem infrastructure matured through integration of simulation training software into all da Vinci 5 systems. Research continued advancing autonomous capabilities: SRT-H gallbladder autonomy maintained 100% accuracy; UCSD suturing pipeline demonstrated 400+ trials of state-of-the-art performance. Critical expert commentary emphasised gap between technical breakthroughs and clinical readiness, highlighting human factors and biological variability unaddressed in ex vivo validation. Platform reliability concerns persisted: Class 2 FDA recall issued December 2025 (144 da Vinci 5 units) for Surgeon Console connector. Regulatory expansion occurred with FDA clearance of da Vinci SP for three general surgery procedures. Critical adoption barriers remained entrenched: no randomized trials proving clinical benefit, no regulatory pathways for autonomous feature integration, liability frameworks undefined, constraining deployment beyond specialist centres despite mature technical capability and emerging market traction.
- **2025-Q3:** Major breakthrough in autonomous surgical procedure comprehension: Johns Hopkins and Stanford's SRT-H AI system achieved 100% accuracy performing autonomous gallbladder removal on ex vivo models, advancing from task-specific execution to procedural understanding. Concurrent academic progress in autonomous suturing: UCSD pipeline continued refining suture manipulation with 400+ trials demonstrating state-of-the-art accuracy, and NeurIPS 2025 introduced SutureBot benchmark (1,890 suturing demonstrations) enabling 59-74% precision improvements. Systematic review of 32 studies documented growing research momentum in autonomous surgical assistants, with emerging progress in tool manipulation and persistent challenges in procedural awareness. Moon Surgical's Maestro continued commercial scaling with 1,600+ global procedures across 60 surgical types. Critical barriers remained: regulatory frameworks undefined, clinical outcome evidence absent, platform reliability concerns ongoing, and liability standards unresolved—limiting deployment to specialist centres and research institutions.
- **2025-Q2:** Moon Surgical's Maestro semi-autonomous laparoscopic system reached inflection-point commercial adoption with 1,600+ total procedures (1,400 in preceding year) across 60 surgical types, demonstrating rapid scaling from clinical trials into multi-site ambulatory deployment. Second-generation system rolled out in France with advanced AI for setup automation and vision control, and company expanded leadership teams for U.S. commercialization. Institutional research validated semi-autonomous execution across surgical domains: translational study demonstrated superior accuracy in dental implant placement with zero complications across 60 human participants. Industry projections predicted global autonomous surgical robotics market exceeding €10 billion by 2033, reflecting sector confidence. However, regulatory pathways for autonomous features remained undefined, no completed randomized trials demonstrated clinical benefit, platform reliability concerns persisted, and liability frameworks remained unresolved—constraining adoption beyond specialist centres and research institutions.
- **2025-Q1:** Vision-language imitation learning advanced autonomous task execution: researchers integrated vision-language models trained on 20 hours of surgical video with da Vinci robots, achieving zero-shot autonomous performance on tissue manipulation, needle use, and suturing with problem-solving capability (autonomous needle retrieval). Reinforcement learning frameworks for autonomous suturing demonstrated higher accuracy than teleoperation on synthetic tissue. Intuitive Surgical's da Vinci 5 achieved broad market adoption (2,500+ surgeons, 493 units in Q4 2024, 40+ procedure types), establishing the computing platform foundation for autonomous feature integration. However, platform reliability challenges emerged: Class 2 FDA recall (March 2025) of da Vinci 5 due to faulty foot pedal springs (439 units affected) reinforced safety and liability barriers constraining autonomous deployment despite technical progress. Field remained at clinical validation stage with mature autonomous subtask demonstrations but unresolved platform reliability and outcome evidence gaps.
- **2024-Q4:** Field matured toward clinical deployment and industry standardization. Johns Hopkins demonstrated major imitation learning breakthrough: robots trained directly from surgical video achieved human-equivalent performance without manual programming, reducing dependency on hand-coded procedures and advancing feasibility of generalizable autonomous surgical systems. Moon Surgical's Maestro completed first-in-human clinical validation with 30 successful laparoscopic procedures at CHU Saint-Pierre teaching hospital, transitioning from research trial to clinical evidence. Regulatory landscape clarified through market analysis documenting divergence between FDA's SaMD approval pathway and EU Medical Device Regulation (MDR) requirements, identifying harmonization challenges constraining international deployment of AI-enabled autonomous systems. Expert consensus from Johns Hopkins robotics panel emphasized human-machine complementarity and surgeon oversight as realistic near-term pathway rather than full autonomy, reflecting tempered expectations within leading research institutions. Platform reliability concerns persisted, constraining adoption momentum despite technical progress.
- **2024-Q3:** Research and commercial momentum accelerated around autonomous surgical task execution. Major institutional funding commitment: ARPA-H awarded up to $12M to a multi-institution consortium (Vanderbilt, Johns Hopkins, Utah) for developing fully autonomous surgical robot for tumor removal, with 3-year demonstration goal in simulated conditions. Autonomous suturing research reached state-of-the-art: UC San Diego's image-to-grasp pipeline demonstrated over 400 grasping trials with high accuracy for autonomous thread manipulation. Autonomous needle steering for MRI-guided prostate procedures advanced feasibility in critical surgical applications. ICRA 2024 hosted a full-day workshop on autonomy in surgical robotics, bringing together industry and academic leaders to address regulatory challenges (EU AI Act) and clinical integration pathways. Commercial deployments evolved: Moon Surgical's Maestro reported 250+ patients treated across multiple hospitals (up from 200 in Q1), and Medical Microinstruments' Symani received FDA De Novo clearance for reconstructive microsurgery with first U.S. clinical cases completed. Intuitive Surgical's Q2 patent filings showed continued focus on autonomous procedure stage determination for context-aware surgical assistance. Regulatory frameworks and unproven clinical benefit remained principal barriers to scaling beyond specialist centres and research-active institutions.
- **2024-Q2:** Systematic reviews documented regulatory and technical maturity in the field: FDA autonomy classification review found regulatory frameworks lagging behind technical capability (86% FDA-cleared systems at Level 1 autonomy, only 2 with ML capabilities), while autonomous suturing literature showed sustained 41-paper research ecosystem demonstrating feasibility progress in core subtasks. Persistent reliability barriers remained: legal analysis identified mechanical failures, software glitches, and programming errors as common complications constraining adoption. Regulatory approval frameworks for autonomous features and clinical outcome evidence remained the primary barriers to scale beyond specialist centres.
- **2024-Q1:** Major commercialisation milestone: Intuitive Surgical released da Vinci 5 (FDA March 2024) with 10,000x greater AI-enabling computing power and force feedback reducing tissue trauma by 43%, positioning the platform for autonomous feature integration at scale. Moon Surgical's Maestro reached commercial deployment with 200+ patients treated across 2 French hospitals, demonstrating transition from clinical trial to multi-site adoption of dedicated semi-autonomous laparoscopic assistance. Regulatory momentum continued. However, fatal injury lawsuits and ongoing device recalls reinforced safety and liability concerns constraining adoption; clinical benefit remained unproven with no completed randomized trials.
- **2023-H2:** Research acceleration demonstrated tangible progress in autonomous subtasks: Johns Hopkins published advances in single-arm autonomous suturing with integrated thread management and autonomous vaginal cuff closure outperforming human surgeons in synthetic tissue validation; independent research validated mental workload-based semi-autonomous suction assistance and soft tissue retraction via reinforcement learning. Intuitive Surgical's 2023 results showed sustained da Vinci platform adoption (14 million cumulative procedures, 22% annual growth), indicating continued market expansion. However, adoption barriers remained entrenched: no randomized trials proved semi-autonomous execution improves patient outcomes; regulatory pathways for autonomous features stayed undefined; platform reliability issues persisted; and liability frameworks lacked clarity, constraining deployment beyond clinical trials and research settings.
- **2023-H1:** Moon Surgical's Maestro semi-autonomous laparoscopic system achieved CE Mark regulatory approval (April 2023) with a 50-patient clinical trial underway in Brussels, marking the first regulatory approval of a dedicated semi-autonomous surgical assistance platform. Concurrent platform reliability concerns emerged: German health authorities issued urgent field safety notices for da Vinci systems (March 2023), indicating ongoing device malfunction and corrective action requirements that constrain autonomous system integration. Research ecosystem continued to expand but adoption barriers persisted: surgeon interest in AI-based autonomous assistance remained high, yet no peer-reviewed evidence demonstrated outcome benefits, regulatory pathways for autonomous systems remained undefined, and liability frameworks remained unsettled.
- **2022-H2:** Research momentum continued with robotic systems demonstrating improved microsurgical precision in wristed instruments and autonomous suturing frameworks winning academic competitions. Johns Hopkins and institutional research mapped autonomy trends across 4,000+ telerobots in daily use. However, adoption barriers solidified: international survey of 2,191 respondents revealed persistent liability and blame-allocation concerns even in fully autonomous scenarios; systematic review identified deep learning barriers including computational demands, data scarcity, and surgeon knowledge gaps. Field remains at research-to-clinical transition stage with mature technical capability but unresolved governance and regulatory pathways.
- **2022-H1:** Johns Hopkins STAR robot achieved first autonomous laparoscopic intestinal anastomosis on pig tissues with results superior to human surgeons, demonstrating significant technical progress. Field expanded beyond task-specific research: systematic reviews confirmed supervised autonomous systems are active research area facing ethico-legal hurdles; neurotechnology-enabled semi-autonomous assistance (EEG-driven suction support) showed promise for surgeon-robot collaboration. However, critical adoption barriers emerged: FDA MAUDE database analysis revealed 84.5% instrument malfunction rates and 15.6% patient injury rates in existing da Vinci platforms; legal malpractice analysis identified substantial liability risks that inform autonomous system regulatory trajectory. Industry standardization efforts began with expert consensus on AI and autonomy definitions, signaling field maturation.
- **2021:** First in vivo autonomous laparoscopic surgery (intestinal anastomosis) demonstrated on porcine models with level 3 autonomy, outperforming human surgeons on consistency and accuracy; imitation learning approaches enabled autonomous surgical tasks (tissue manipulation, needle handling, knot-tying) on da Vinci; human clinical trials on autonomous cardiac interventions registered. Concurrently, research community assessment reveals critical maturity gaps: systematic review of 35 AI studies found no evidence that AI can identify patient outcome-determining surgical tasks, and clinical researchers increasingly advocate for enhancement-focused collaboration over autonomous execution.
- **2020:** First clinical trial data on autonomous robotic-assisted urology surgery published; preclinical research validated autonomous micro-suturing (0.27mm accuracy) and semi-autonomous tissue retraction with deep learning; 83% of surgeons expressed willingness to adopt AI-based autonomous surgical assistants; emerging concerns about system reliability and complication rates in production robotic platforms.

## Tools

- [da Vinci Research Kit (dVRK)](https://github.com/jhu-dvrk/sawIntuitiveResearchKit)

_Source: https://www.thestateofplay.ai/practice/surgical-robotics-semi-autonomous-procedures — CC BY 4.0._